| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | FOXO3 FOXN1 SP2 TCF4 ZBTB2 SALL3 GCM2 FOXP2 VEZF1 ZNF652 SOX30 ZNF280C SREBF1 ADNP2 SAMD7 RFX7 SKIL ATF6B ZEB2 CIC USF3 DMRT3 FOXD4L1 SATB1 ZFHX4 GLI3 ZSCAN5C CARF GMEB1 PLAGL1 FOXP1 MNT MYB | 5.65e-07 | 1412 | 183 | 33 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | FOXO3 SP2 TCF4 ZBTB2 SALL3 GCM2 FOXP2 VEZF1 ZNF652 SOX30 ZNF280C SREBF1 RFX7 SKIL ATF6B ZEB2 CIC USF3 DMRT3 FOXD4L1 SATB1 ZFHX4 GLI3 ZSCAN5C CARF GMEB1 PLAGL1 FOXP1 SNAPC4 MNT MYB | 9.25e-06 | 1459 | 183 | 31 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | FOXO3 SP2 TCF4 ZBTB2 SALL3 GCM2 FOXP2 ZNF652 SOX30 ZNF280C SREBF1 RFX7 SKIL ATF6B ZEB2 DMRT3 FOXD4L1 SATB1 ZFHX4 GLI3 ZSCAN5C CARF GMEB1 PLAGL1 FOXP1 SNAPC4 MNT MYB | 9.32e-06 | 1244 | 183 | 28 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | FOXO3 SP2 TCF4 ZBTB2 SALL3 GCM2 FOXP2 ZNF652 SOX30 ZNF280C SREBF1 RFX7 SKIL ATF6B ZEB2 DMRT3 FOXD4L1 SATB1 ZFHX4 GLI3 ZSCAN5C CARF GMEB1 PLAGL1 FOXP1 SNAPC4 MNT MYB | 1.38e-05 | 1271 | 183 | 28 | GO:0000987 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.10e-05 | 37 | 183 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.40e-05 | 38 | 183 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | FOXO3 SP2 ZBTB2 FOXP2 SOX30 SAMD7 SKIL ZEB2 SATB1 PLAGL1 FOXP1 MNT | 4.14e-05 | 320 | 183 | 12 | GO:0001227 |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | FOXO3 SP2 ZBTB2 FOXP2 SOX30 SAMD7 SKIL ZEB2 SATB1 PLAGL1 FOXP1 MNT | 4.95e-05 | 326 | 183 | 12 | GO:0001217 |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.18e-04 | 11 | 183 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | potassium channel inhibitor activity | 1.18e-04 | 11 | 183 | 3 | GO:0019870 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 1.21e-04 | 120 | 183 | 7 | GO:0008013 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 1.57e-04 | 12 | 183 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | chromatin binding | FOXO3 TCF4 NCOA6 EP400 STAG1 SREBF1 SAMD7 SKIL CIC SATB1 ATXN1 GLI3 SMARCC2 FOXP1 MBD5 MNT CBX2 | 4.71e-04 | 739 | 183 | 17 | GO:0003682 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | FOXO3 FOXN1 TCF4 GCM2 VEZF1 SOX30 SREBF1 ATF6B ZEB2 USF3 CARF GMEB1 PLAGL1 MYB | 6.75e-04 | 560 | 183 | 14 | GO:0001228 |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | FOXO3 FOXN1 TCF4 GCM2 VEZF1 SOX30 SREBF1 ATF6B ZEB2 USF3 CARF GMEB1 PLAGL1 MYB | 7.49e-04 | 566 | 183 | 14 | GO:0001216 |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 8.20e-04 | 5 | 183 | 2 | GO:1990269 | |
| GeneOntologyMolecularFunction | ion channel inhibitor activity | 9.70e-04 | 48 | 183 | 4 | GO:0008200 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 1.13e-03 | 50 | 183 | 4 | GO:0016248 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 1.22e-03 | 51 | 183 | 4 | GO:0141110 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | FOXO3 SP2 TCF4 ZBTB2 MAGEL2 FOXP2 SCAF8 SOX30 SREBF1 SAMD7 SKIL ZEB2 CIC SCAF4 NEDD4 SATB1 ATXN1 GLI3 SMARCC2 PLAGL1 FOXP1 IRF2BPL SAP130 MAGEC2 MNT MYB CBX2 | 5.34e-07 | 1053 | 181 | 27 | GO:0000122 |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription | 2.64e-06 | 4 | 181 | 3 | GO:1904594 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | FOXO3 SP2 TCF4 ZBTB2 MAGEL2 FOXP2 SCAF8 SOX30 SREBF1 SAMD7 SKIL ZEB2 CIC SCAF4 TNFRSF4 NEDD4 SATB1 PTPRK ATXN1 GLI3 SMARCC2 PLAGL1 FOXP1 IRF2BPL YY1AP1 SAP130 MAGEC2 MNT MYB CBX2 | 4.69e-06 | 1399 | 181 | 30 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | FOXO3 SP2 TCF4 ZBTB2 MAGEL2 FOXP2 SCAF8 SOX30 SREBF1 SAMD7 SKIL ZEB2 CIC SCAF4 TNFRSF4 NEDD4 SATB1 PTPRK ATXN1 GLI3 SMARCC2 PLAGL1 FOXP1 IRF2BPL YY1AP1 SAP130 MAGEC2 MNT MYB CBX2 | 5.71e-06 | 1413 | 181 | 30 | GO:1902679 |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 1.30e-05 | 6 | 181 | 3 | GO:0031554 | |
| GeneOntologyBiologicalProcess | positive regulation of potassium ion import across plasma membrane | 2.27e-05 | 7 | 181 | 3 | GO:1903288 | |
| GeneOntologyBiologicalProcess | negative regulation of sodium ion transport | 3.71e-05 | 22 | 181 | 4 | GO:0010766 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 5.16e-05 | 192 | 181 | 9 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of potassium ion import | 5.37e-05 | 9 | 181 | 3 | GO:1903286 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 7.66e-05 | 2 | 181 | 2 | GO:2000805 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of RNA polymerase II transcription | 7.66e-05 | 2 | 181 | 2 | GO:0120191 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | FOXO3 TET2 FOXN1 TCF4 NCOA6 GCM2 VEZF1 SOX30 ECD SREBF1 MAML1 RFX7 ATF6B ZEB2 TSC22D1 USF3 ATXN1 GLI3 CARF GMEB1 PLAGL1 FOXP1 IRF2BPL TAF6 MED26 TP53BP1 MYB | 8.25e-05 | 1390 | 181 | 27 | GO:0045944 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | FAT4 DSG1 ITGAL WNK1 CADM2 PTPRS DCHS1 ROBO2 RIC8A IGSF9B PLXNB3 | 1.05e-04 | 313 | 181 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | DNA damage response | FOXO3 ERVK-6 NCOA6 BCL2L11 EP400 PIDD1 HUWE1 SKIL EMSY NEDD4 PPP1R10 HROB NYNRIN ERVK-8 OTUD4 SMARCC2 FOXP1 TNKS1BP1 HERC2 TAF6 TP53BP1 | 1.08e-04 | 959 | 181 | 21 | GO:0006974 |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 RAPH1 MAP6 DAG1 DCC SKIL ZEB2 PTK2 CDKL5 PLPPR4 PTPRS GLI3 ROBO2 FOXP1 PLXNB3 | 1.47e-04 | 566 | 181 | 15 | GO:0007409 |
| GeneOntologyBiologicalProcess | DNA integration | 1.78e-04 | 13 | 181 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 2.28e-04 | 3 | 181 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription, poly(A)-coupled | 2.28e-04 | 3 | 181 | 2 | GO:0030846 | |
| GeneOntologyBiologicalProcess | innate vocalization behavior | 2.28e-04 | 3 | 181 | 2 | GO:0098582 | |
| GeneOntologyBiologicalProcess | regulation of termination of RNA polymerase II transcription, poly(A)-coupled | 2.28e-04 | 3 | 181 | 2 | GO:2000804 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 3.06e-04 | 354 | 181 | 11 | GO:0050769 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 HSPG2 RAPH1 MAP6 DAG1 DCC SKIL ZEB2 PTK2 NEDD4 CDKL5 PLPPR4 PTPRS GLI3 ROBO2 FOXP1 PLXNB3 | 3.29e-04 | 748 | 181 | 17 | GO:0048667 |
| GeneOntologyBiologicalProcess | termination of RNA polymerase II transcription | 3.42e-04 | 16 | 181 | 3 | GO:0006369 | |
| GeneOntologyCellularComponent | chromatin | FOXO3 FOXN1 SP2 TCF4 GCM2 EP400 STAG1 FOXP2 BICRA SOX30 SREBF1 ADNP2 SRCAP RFX7 ATF6B ZEB2 CIC NEDD4 PPP1R10 DMRT3 FOXD4L1 SATB1 ZFHX4 GMEB1 SMARCC2 FOXP1 YY1AP1 TNKS1BP1 TAF6 SAP130 MNT CBX2 | 2.49e-06 | 1480 | 186 | 32 | GO:0000785 |
| GeneOntologyCellularComponent | nuclear body | WBP11 EP400 STAG1 RAPH1 MAML1 SRSF11 SREK1 SRCAP SKIL CHAMP1 PTK2 PPP1R10 SATB1 GLI3 SCN1A PLAGL1 YY1AP1 SRRM2 SAP130 TAP2 TP53BP1 SON | 1.86e-05 | 903 | 186 | 22 | GO:0016604 |
| HumanPheno | Self-injurious behavior | HSPG2 TCF4 FAT4 MAGEL2 PIDD1 RFX7 SCAF4 CDKL5 NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 MBD5 | 3.75e-07 | 210 | 67 | 14 | HP:0100716 |
| HumanPheno | Restricted or repetitive behaviors or interests | TANC2 HSPG2 TCF4 MAGEL2 BICRA PIDD1 HUWE1 SRCAP RFX7 CHAMP1 ZEB2 CIC CDKL5 SATB1 SCN1A FOXP1 HERC2 MBD5 | 6.65e-07 | 368 | 67 | 18 | HP:0031432 |
| HumanPheno | Perseverative thought | TANC2 HSPG2 TCF4 MAGEL2 BICRA PIDD1 HUWE1 SRCAP RFX7 CHAMP1 ZEB2 CIC CDKL5 SATB1 SCN1A FOXP1 HERC2 MBD5 | 9.51e-07 | 377 | 67 | 18 | HP:0030223 |
| HumanPheno | Disordered formal thought process | TANC2 HSPG2 TCF4 MAGEL2 BICRA PIDD1 HUWE1 SRCAP RFX7 CHAMP1 ZEB2 CIC CDKL5 SATB1 SCN1A FOXP1 HERC2 MBD5 | 1.35e-06 | 386 | 67 | 18 | HP:0025769 |
| HumanPheno | Abnormality of pain sensation | 1.66e-06 | 113 | 67 | 10 | HP:0010832 | |
| HumanPheno | Motor stereotypy | TANC2 HSPG2 TCF4 BICRA HUWE1 RFX7 CHAMP1 ZEB2 CIC CDKL5 SATB1 SCN1A FOXP1 HERC2 MBD5 | 2.25e-06 | 280 | 67 | 15 | HP:0000733 |
| HumanPheno | Abnormal thought pattern | TANC2 HSPG2 TCF4 MAGEL2 BICRA PIDD1 HUWE1 SRCAP RFX7 CHAMP1 ZEB2 CIC CDKL5 SATB1 SCN1A FOXP1 HERC2 MBD5 | 2.61e-06 | 404 | 67 | 18 | HP:5200269 |
| HumanPheno | Disinhibition | TANC2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 4.20e-06 | 807 | 67 | 26 | HP:0000734 |
| HumanPheno | Inappropriate behavior | TANC2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 4.20e-06 | 807 | 67 | 26 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | TANC2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 4.20e-06 | 807 | 67 | 26 | HP:5200123 |
| HumanPheno | Social disinhibition | TANC2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 4.20e-06 | 807 | 67 | 26 | HP:5200029 |
| HumanPheno | Abnormally increased volition | TANC2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 SATB1 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 5.03e-06 | 869 | 67 | 27 | HP:5200263 |
| HumanPheno | Esodeviation | MAGEL2 FOXP2 SREBF1 PIDD1 HUWE1 ZEB2 SCAF4 CDKL5 NPAP1 IRF2BPL HERC2 MBD5 SON | 8.85e-06 | 236 | 67 | 13 | HP:0020045 |
| HumanPheno | Impaired pain sensation | 1.16e-05 | 84 | 67 | 8 | HP:0007328 | |
| HumanPheno | Abnormal social development | TANC2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 HERC1 TAF6 MBD5 SRRM2 | 1.18e-05 | 908 | 67 | 27 | HP:0025732 |
| HumanPheno | Congenital abnormal hair pattern | HSPG2 TCF4 FAT4 WBP11 MAGEL2 BICRA HUWE1 SRCAP SATB1 NPAP1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 | 1.52e-05 | 327 | 67 | 15 | HP:0011361 |
| HumanPheno | Hypermetropia | HSPG2 MAGEL2 PDGFRB BICRA HUWE1 SRCAP CHAMP1 GPR179 SATB1 NPAP1 HERC2 MBD5 SRRM2 SON | 1.60e-05 | 288 | 67 | 14 | HP:0000540 |
| HumanPheno | Hyperactivity | TANC2 HSPG2 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CIC CDKL5 SCN1A NPAP1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 1.80e-05 | 558 | 67 | 20 | HP:0000752 |
| HumanPheno | Aplasia/Hypoplasia involving bones of the feet | HSPG2 TCF4 FAT4 MAGEL2 PDGFRB HUWE1 CDKL5 SATB1 GLI3 NPAP1 DCHS1 HERC2 MBD5 SON | 2.36e-05 | 298 | 67 | 14 | HP:0006494 |
| HumanPheno | Short foot | 2.53e-05 | 153 | 67 | 10 | HP:0001773 | |
| HumanPheno | Short feet | 2.53e-05 | 153 | 67 | 10 | HP:0001766 | |
| HumanPheno | Small feet | 2.53e-05 | 153 | 67 | 10 | HP:0001764 | |
| HumanPheno | Poor fine motor coordination | 2.80e-05 | 69 | 67 | 7 | HP:0007010 | |
| HumanPheno | Autistic behavior | TANC2 HSPG2 TCF4 MAGEL2 STAG1 FOXP2 BICRA SRCAP RFX7 CIC SCAF4 CDKL5 USF3 SATB1 SCN1A NPAP1 SMARCC2 FOXP1 HERC2 MBD5 SRRM2 SON | 2.90e-05 | 678 | 67 | 22 | HP:0000729 |
| HumanPheno | Diagnostic behavioral phenotype | TANC2 HSPG2 TCF4 MAGEL2 STAG1 FOXP2 PDGFRB BICRA SRCAP RFX7 CIC SCAF4 CDKL5 USF3 SATB1 SCN1A NPAP1 SMARCC2 FOXP1 HERC2 MBD5 SRRM2 SON | 4.17e-05 | 747 | 67 | 23 | HP:0025783 |
| HumanPheno | Myopia | HSPG2 TCF4 MAGEL2 BICRA DAG1 HUWE1 SRCAP ZEB2 GPR179 COL18A1 USF3 NPAP1 SMARCC2 HERC2 HERC1 MBD5 SON | 4.33e-05 | 447 | 67 | 17 | HP:0000545 |
| HumanPheno | Reduced impulse control | TANC2 TET2 HSPG2 TCF4 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 SATB1 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 4.37e-05 | 1032 | 67 | 28 | HP:5200045 |
| HumanPheno | Micropenis | TCF4 FAT4 MAGEL2 HUWE1 DCC ZEB2 CDKL5 GLI3 NPAP1 HERC2 HERC1 MBD5 SRRM2 | 5.10e-05 | 278 | 67 | 13 | HP:0000054 |
| HumanPheno | Talipes equinovalgus | 5.13e-05 | 166 | 67 | 10 | HP:0001772 | |
| HumanPheno | Abnormality of refraction | HSPG2 TCF4 MAGEL2 PDGFRB BICRA DAG1 HUWE1 SRCAP CHAMP1 ZEB2 GPR179 COL18A1 USF3 SATB1 NPAP1 SMARCC2 FOXP1 HERC2 HERC1 MBD5 SRRM2 SON | 5.85e-05 | 709 | 67 | 22 | HP:0000539 |
| HumanPheno | Frontal upsweep of hair | 6.04e-05 | 33 | 67 | 5 | HP:0002236 | |
| HumanPheno | Polyphagia | 6.25e-05 | 78 | 67 | 7 | HP:0002591 | |
| HumanPheno | Esotropia | MAGEL2 SREBF1 PIDD1 HUWE1 ZEB2 CDKL5 NPAP1 IRF2BPL HERC2 MBD5 SON | 6.93e-05 | 208 | 67 | 11 | HP:0000565 |
| HumanPheno | Abnormal scrotum morphology | 8.99e-05 | 143 | 67 | 9 | HP:0000045 | |
| HumanPheno | Abnormality of mouth shape | HSPG2 TCF4 FAT4 MAGEL2 SRCAP CHAMP1 ZEB2 NPAP1 DCHS1 FOXP1 HERC2 MBD5 SON | 9.10e-05 | 294 | 67 | 13 | HP:0011338 |
| HumanPheno | Tube feeding | COL7A1 FAT4 MAGEL2 FOXP2 SRCAP CDKL5 SCN1A NPAP1 DCHS1 HERC2 SON | 9.36e-05 | 215 | 67 | 11 | HP:0033454 |
| HumanPheno | Broad foot | 9.72e-05 | 179 | 67 | 10 | HP:0001769 | |
| HumanPheno | Poor motor coordination | 1.09e-04 | 85 | 67 | 7 | HP:0002275 | |
| HumanPheno | Narrow forehead | 1.22e-04 | 184 | 67 | 10 | HP:0000341 | |
| HumanPheno | Poor gross motor coordination | 1.38e-04 | 21 | 67 | 4 | HP:0007015 | |
| HumanPheno | Recurrent maladaptive behavior | TANC2 TET2 HSPG2 TCF4 COL7A1 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB BICRA PIDD1 HUWE1 SRCAP RFX7 CHAMP1 ZEB2 CIC SCAF4 CDKL5 SATB1 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 1.57e-04 | 1293 | 67 | 31 | HP:5200241 |
| HumanPheno | Small hand | 1.72e-04 | 122 | 67 | 8 | HP:0200055 | |
| HumanPheno | Abnormal hair whorl | 1.98e-04 | 42 | 67 | 5 | HP:0010721 | |
| HumanPheno | Hypoplasia of penis | HSPG2 TCF4 FAT4 MAGEL2 DAG1 HUWE1 DCC ZEB2 CDKL5 GLI3 NPAP1 HERC2 HERC1 MBD5 SRRM2 | 1.98e-04 | 408 | 67 | 15 | HP:0008736 |
| HumanPheno | Delayed speech and language development | TANC2 HSPG2 TCF4 MAGEL2 STAG1 FOXP2 DAG1 HUWE1 DCC SRCAP RFX7 CHAMP1 ZEB2 CIC SCAF4 CDKL5 SATB1 GLI3 SCN1A NPAP1 SMARCC2 FOXP1 IRF2BPL HERC2 HERC1 MBD5 SRRM2 OTOG | 2.09e-04 | 1123 | 67 | 28 | HP:0000750 |
| HumanPheno | Drooling | 2.23e-04 | 161 | 67 | 9 | HP:0002307 | |
| HumanPheno | Abnormal eating behavior | 2.40e-04 | 128 | 67 | 8 | HP:0100738 | |
| HumanPheno | Hypoplastic male external genitalia | HSPG2 TCF4 FAT4 MAGEL2 STAG1 DAG1 HUWE1 DCC RFX7 ZEB2 CDKL5 GLI3 NPAP1 HERC2 HERC1 MBD5 SRRM2 | 2.47e-04 | 514 | 67 | 17 | HP:0000050 |
| HumanPheno | Intellectual disability, severe | TCF4 FAT4 STAG1 DAG1 ZEB2 SATB1 GLI3 SCN1A DCHS1 SMARCC2 FOXP1 HERC1 MBD5 SON | 2.56e-04 | 371 | 67 | 14 | HP:0010864 |
| HumanPheno | Short attention span | TANC2 HSPG2 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 SRCAP RFX7 CIC SATB1 SCN1A NPAP1 FOXP1 HERC2 MBD5 SRRM2 | 2.65e-04 | 517 | 67 | 17 | HP:0000736 |
| HumanPheno | Abnormal hair pattern | HSPG2 TCF4 FAT4 WBP11 MAGEL2 STAG1 BICRA HUWE1 SRCAP ZEB2 CDKL5 SATB1 GLI3 SCN1A NPAP1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 | 2.79e-04 | 676 | 67 | 20 | HP:0010720 |
| HumanPheno | Constipation | TANC2 HSPG2 TCF4 COL7A1 MAGEL2 BICRA SREBF1 SRCAP RFX7 ZEB2 CDKL5 SATB1 NPAP1 FOXP1 HERC2 MBD5 | 2.98e-04 | 472 | 67 | 16 | HP:0002019 |
| HumanPheno | Submucous cleft hard palate | 3.26e-04 | 72 | 67 | 6 | HP:0000176 | |
| HumanPheno | Submucous cleft of soft and hard palate | 3.26e-04 | 72 | 67 | 6 | HP:0410031 | |
| HumanPheno | Reduced attention regulation | TANC2 HSPG2 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 SRCAP RFX7 CIC SATB1 SCN1A NPAP1 FOXP1 HERC2 MBD5 SRRM2 | 3.27e-04 | 526 | 67 | 17 | HP:5200044 |
| HumanPheno | Class III obesity | 3.33e-04 | 11 | 67 | 3 | HP:0025501 | |
| HumanPheno | Excessive salivation | 3.36e-04 | 170 | 67 | 9 | HP:0003781 | |
| HumanPheno | Abnormal hippocampus morphology | 3.74e-04 | 48 | 67 | 5 | HP:0025100 | |
| HumanPheno | Thin upper lip vermilion | MAGEL2 PDGFRB HUWE1 SRCAP RFX7 CHAMP1 SCN1A NPAP1 SMARCC2 HERC2 TAF6 MBD5 SRRM2 | 3.78e-04 | 339 | 67 | 13 | HP:0000219 |
| HumanPheno | Thin lips | MAGEL2 PDGFRB HUWE1 SRCAP RFX7 CHAMP1 SCN1A NPAP1 SMARCC2 HERC2 TAF6 MBD5 SRRM2 | 3.78e-04 | 339 | 67 | 13 | HP:0000213 |
| HumanPheno | Submucous cleft lip/palate | 3.79e-04 | 74 | 67 | 6 | HP:0000208 | |
| HumanPheno | Abnormal upper lip morphology | HSPG2 TCF4 FAT4 MAGEL2 FOXP2 PDGFRB HUWE1 SRCAP RFX7 CHAMP1 ZEB2 SCAF4 GREB1L CDKL5 SATB1 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 HERC2 TAF6 MBD5 SRRM2 SON | 3.91e-04 | 980 | 67 | 25 | HP:0000177 |
| HumanPheno | Abnormal morphology of the limbic system | 4.13e-04 | 49 | 67 | 5 | HP:0007343 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | TCF4 FAT4 MAGEL2 PDGFRB BICRA HUWE1 SRCAP CDKL5 SATB1 GLI3 NPAP1 DCHS1 SMARCC2 YY1AP1 HERC2 MBD5 SON | 4.27e-04 | 538 | 67 | 17 | HP:0005927 |
| HumanPheno | Abnormality of salivation | MAGEL2 FOXP2 CHAMP1 ZEB2 SATB1 SCN1A FOXP1 HERC1 SNAPC4 MBD5 | 4.36e-04 | 215 | 67 | 10 | HP:0100755 |
| HumanPheno | Paroxysmal bursts of laughter | 4.40e-04 | 12 | 67 | 3 | HP:0000749 | |
| HumanPheno | Cleft hard palate | 4.70e-04 | 77 | 67 | 6 | HP:0410005 | |
| HumanPheno | Abnormal exteroceptive sensation | TET2 MAGEL2 RFX7 WNK1 CHAMP1 ZEB2 CDKL5 ATXN1 SCN1A NPAP1 HERC2 | 4.81e-04 | 259 | 67 | 11 | HP:0033747 |
| HumanPheno | Language impairment | TANC2 HSPG2 TCF4 MAGEL2 STAG1 FOXP2 DAG1 HUWE1 DCC SRCAP RFX7 CHAMP1 ZEB2 CIC SCAF4 CDKL5 SATB1 GLI3 SCN1A NPAP1 SMARCC2 FOXP1 IRF2BPL HERC2 HERC1 MBD5 SRRM2 OTOG | 4.85e-04 | 1178 | 67 | 28 | HP:0002463 |
| HumanPheno | External genital hypoplasia | HSPG2 TCF4 FAT4 MAGEL2 STAG1 DAG1 HUWE1 DCC RFX7 ZEB2 CDKL5 GLI3 NPAP1 HERC2 HERC1 MBD5 SRRM2 | 4.87e-04 | 544 | 67 | 17 | HP:0003241 |
| HumanPheno | Delayed ability to walk | MAGEL2 DAG1 HUWE1 SRCAP CHAMP1 ZEB2 SCAF4 SATB1 FOXP1 HERC2 SRRM2 SON | 5.05e-04 | 304 | 67 | 12 | HP:0031936 |
| HumanPheno | Bilateral choanal atresia/stenosis | 5.07e-04 | 3 | 67 | 2 | HP:0200138 | |
| HumanPheno | Downturned corners of mouth | 5.55e-04 | 182 | 67 | 9 | HP:0002714 | |
| HumanPheno | Abnormal penis morphology | HSPG2 TCF4 FAT4 MAGEL2 BICRA DAG1 HUWE1 DCC SRCAP ZEB2 CDKL5 USF3 GLI3 NPAP1 DCHS1 SMARCC2 HERC2 HERC1 MBD5 SRRM2 | 5.59e-04 | 712 | 67 | 20 | HP:0000036 |
| HumanPheno | Precocious puberty | 6.51e-04 | 186 | 67 | 9 | HP:0000826 | |
| HumanPheno | Abnormal motivation | TANC2 HSPG2 TCF4 COL7A1 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 SATB1 ATXN1 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 6.59e-04 | 1263 | 67 | 29 | HP:5200275 |
| HumanPheno | Abnormal volitional state | TANC2 HSPG2 TCF4 COL7A1 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 SATB1 ATXN1 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 6.59e-04 | 1263 | 67 | 29 | HP:0025780 |
| HumanPheno | Submucous cleft palate | 7.04e-04 | 83 | 67 | 6 | HP:5201016 | |
| HumanPheno | Impairment in personality functioning | TANC2 HSPG2 TCF4 COL7A1 FAT4 WBP11 MAGEL2 FOXP2 PDGFRB PIDD1 HUWE1 SRCAP RFX7 CHAMP1 CIC SCAF4 CDKL5 GLI3 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 TAF6 MBD5 SRRM2 | 7.07e-04 | 1141 | 67 | 27 | HP:0031466 |
| HumanPheno | Low 5-minute APGAR score | 7.14e-04 | 14 | 67 | 3 | HP:0030919 | |
| HumanPheno | Early onset of sexual maturation | 7.31e-04 | 189 | 67 | 9 | HP:0100000 | |
| HumanPheno | Attention deficit hyperactivity disorder | TANC2 HSPG2 WBP11 MAGEL2 PDGFRB PIDD1 SRCAP RFX7 CIC SCN1A NPAP1 FOXP1 HERC2 SRRM2 | 7.67e-04 | 413 | 67 | 14 | HP:0007018 |
| HumanPheno | Expressive language delay | 7.70e-04 | 56 | 67 | 5 | HP:0002474 | |
| HumanPheno | Language delay | 7.70e-04 | 56 | 67 | 5 | HP:0002336 | |
| HumanPheno | Abnormality of upper lip vermillion | FAT4 MAGEL2 PDGFRB HUWE1 SRCAP RFX7 CHAMP1 SCN1A NPAP1 DCHS1 SMARCC2 HERC2 TAF6 MBD5 SRRM2 | 7.93e-04 | 464 | 67 | 15 | HP:0011339 |
| HumanPheno | Aggressive behavior | HSPG2 TCF4 FAT4 MAGEL2 PIDD1 SRCAP RFX7 SCAF4 CDKL5 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 MBD5 | 8.09e-04 | 516 | 67 | 16 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | HSPG2 TCF4 FAT4 MAGEL2 PIDD1 SRCAP RFX7 SCAF4 CDKL5 SCN1A NPAP1 DCHS1 SMARCC2 FOXP1 HERC2 MBD5 | 8.09e-04 | 516 | 67 | 16 | HP:0006919 |
| HumanPheno | Short palm | 8.25e-04 | 118 | 67 | 7 | HP:0004279 | |
| HumanPheno | Steroetypic upper-extremity movements | 8.35e-04 | 57 | 67 | 5 | HP:5200018 | |
| HumanPheno | Abnormal curvature of the vertebral column | TANC2 HSPG2 TCF4 FAT4 MAGEL2 STAG1 FOXP2 PDGFRB BICRA DAG1 HUWE1 DCC SRCAP WNK1 ZEB2 CIC SCAF4 CDKL5 USF3 SATB1 SCN1A NPAP1 DCHS1 SMARCC2 HERC2 HERC1 MBD5 SON | 8.71e-04 | 1219 | 67 | 28 | HP:0010674 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | TCF4 FAT4 MAGEL2 PDGFRB BICRA HUWE1 SRCAP CDKL5 SATB1 GLI3 NPAP1 DCHS1 SMARCC2 YY1AP1 HERC2 MBD5 SON | 8.71e-04 | 572 | 67 | 17 | HP:0006496 |
| HumanPheno | Acromicria | 8.84e-04 | 15 | 67 | 3 | HP:0031878 | |
| HumanPheno | Low 1-minute APGAR score | 8.84e-04 | 15 | 67 | 3 | HP:0030918 | |
| HumanPheno | Clinodactyly | HSPG2 TCF4 FAT4 MAGEL2 STAG1 FOXP2 HUWE1 SRCAP RFX7 NPAP1 DCHS1 SMARCC2 FOXP1 YY1AP1 HERC2 MBD5 WNK3 | 9.06e-04 | 574 | 67 | 17 | HP:0030084 |
| HumanPheno | Heterotropia | MAGEL2 SREBF1 PIDD1 HUWE1 ZEB2 CDKL5 NPAP1 IRF2BPL HERC2 MBD5 SON | 9.54e-04 | 281 | 67 | 11 | HP:0032012 |
| HumanPheno | Abnormal hair morphology | FOXN1 HSPG2 TCF4 COL7A1 FAT4 WBP11 MAGEL2 STAG1 FOXP2 DSG1 PDGFRB BICRA SREBF1 HUWE1 SRCAP ZEB2 CDKL5 COL18A1 USF3 SATB1 GLI3 SCN1A NPAP1 SMARCC2 FOXP1 SLC45A2 HERC2 HERC1 TAF6 MBD5 SON | 9.88e-04 | 1424 | 67 | 31 | HP:0001595 |
| HumanPheno | Aplasia/hypoplasia involving bones of the lower limbs | HSPG2 TCF4 FAT4 MAGEL2 PDGFRB HUWE1 RTN2 CDKL5 SATB1 GLI3 NPAP1 DCHS1 HERC2 MBD5 SON | 9.90e-04 | 474 | 67 | 15 | HP:0006493 |
| HumanPheno | Broad fingertip | 1.01e-03 | 4 | 67 | 2 | HP:0011300 | |
| HumanPheno | Abnormality of mouth size | HSPG2 TCF4 COL7A1 FAT4 STAG1 FOXP2 HUWE1 SRCAP SCN1A DCHS1 SMARCC2 TAF6 MBD5 SON | 1.02e-03 | 425 | 67 | 14 | HP:0011337 |
| HumanPheno | Abnormality of the fourth metatarsal bone | 1.08e-03 | 16 | 67 | 3 | HP:0040035 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | TET2 FOXN1 HSPG2 SP2 NCOA6 MAGEL2 GCM2 FOXP2 VEZF1 PDGFRB MAP6 SREBF1 MAML1 CIC PTK2 NEDD4 PLPPR4 PTPRS SCN1A KIF19 SMARCC2 PLAGL1 FOXP1 HERC2 MBD5 MEX3B MNT TP53BP2 CBX2 | 4.30e-06 | 1124 | 146 | 29 | MP:0011112 |
| MousePheno | postnatal lethality | TET2 FOXN1 SP2 TCF4 COL7A1 MAGEL2 FOXP2 PDGFRB SREBF1 MAML1 CIC SATB1 PLPPR4 PTPRS GLI3 SCN1A KIF19 DCHS1 SMARCC2 ROBO2 PLAGL1 LRRC7 HERC2 MBD5 MNT TP53BP2 CBX2 | 1.85e-05 | 1084 | 146 | 27 | MP:0002082 |
| MousePheno | perinatal lethality, incomplete penetrance | TET2 HSPG2 NCOA6 MAGEL2 GCM2 FOXP2 VEZF1 PDGFRB MAP6 PTPRS SMARCC2 PLAGL1 MBD5 MEX3B MNT TP53BP2 CBX2 | 1.97e-05 | 503 | 146 | 17 | MP:0011090 |
| MousePheno | perinatal lethality | TET2 HSPG2 TCF4 NCOA6 FAT4 MAGEL2 SALL3 GCM2 FOXP2 VEZF1 PDGFRB MAP6 DCC NEDD4 ZFHX4 PTPRS GLI3 SCN1A DCHS1 SMARCC2 ROBO2 PLAGL1 MBD5 MEX3B MNT TP53BP2 CBX2 | 3.85e-05 | 1130 | 146 | 27 | MP:0002081 |
| MousePheno | increased embryo size | 6.01e-05 | 8 | 146 | 3 | MP:0001699 | |
| MousePheno | decreased fibroblast proliferation | 6.14e-05 | 129 | 146 | 8 | MP:0011704 | |
| MousePheno | hyperactivity | TANC2 TCF4 SALL3 MAP6 ADNP2 CIC CDKL5 COL18A1 ARAP3 PXDN SATB1 PTPRK SCN1A CASKIN1 CCDC120 FOXP1 SLC45A2 TNKS1BP1 MICAL3 LRRC7 IGSF9B KLHDC7A MEX3B WNK2 TP53BP2 OTOG SON | 7.22e-05 | 1172 | 146 | 27 | MP:0001399 |
| MousePheno | increased double-negative T cell number | 8.17e-05 | 69 | 146 | 6 | MP:0005090 | |
| MousePheno | abnormal fibroblast physiology | SP2 NCOA6 BCL2L11 STAG1 RAPH1 PDGFRB DCC SKIL PTK2 NEDD4 CBX2 | 1.29e-04 | 271 | 146 | 11 | MP:0020414 |
| MousePheno | abnormal double-negative T cell morphology | 1.70e-04 | 112 | 146 | 7 | MP:0002407 | |
| Domain | Ig_I-set | 1.45e-05 | 190 | 178 | 10 | IPR013098 | |
| Domain | I-set | 1.45e-05 | 190 | 178 | 10 | PF07679 | |
| Domain | OSR1_C | 1.67e-05 | 6 | 178 | 3 | PF12202 | |
| Domain | Kinase_OSR1/WNK_CCT | 1.67e-05 | 6 | 178 | 3 | IPR024678 | |
| Domain | TF_fork_head_CS_2 | 7.42e-05 | 46 | 178 | 5 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 8.24e-05 | 47 | 178 | 5 | IPR018122 | |
| Domain | FH | 1.01e-04 | 49 | 178 | 5 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.01e-04 | 49 | 178 | 5 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.01e-04 | 49 | 178 | 5 | PS00658 | |
| Domain | Fork_head_dom | 1.01e-04 | 49 | 178 | 5 | IPR001766 | |
| Domain | FORK_HEAD_3 | 1.01e-04 | 49 | 178 | 5 | PS50039 | |
| Domain | Forkhead | 1.01e-04 | 49 | 178 | 5 | PF00250 | |
| Domain | HECT | 1.18e-04 | 27 | 178 | 4 | PF00632 | |
| Domain | HECTc | 1.18e-04 | 27 | 178 | 4 | SM00119 | |
| Domain | HECT_dom | 1.18e-04 | 27 | 178 | 4 | IPR000569 | |
| Domain | HECT | 1.18e-04 | 27 | 178 | 4 | PS50237 | |
| Domain | IGc2 | 4.34e-04 | 235 | 178 | 9 | SM00408 | |
| Domain | Ig_sub2 | 4.34e-04 | 235 | 178 | 9 | IPR003598 | |
| Domain | MYB_LIKE | 4.57e-04 | 38 | 178 | 4 | PS50090 | |
| Domain | HSA | 5.35e-04 | 4 | 178 | 2 | SM00573 | |
| Domain | FOXP-CC | 5.35e-04 | 4 | 178 | 2 | PF16159 | |
| Domain | FOXP-CC | 5.35e-04 | 4 | 178 | 2 | IPR032354 | |
| Domain | LRRC37AB_C | 5.35e-04 | 4 | 178 | 2 | IPR029423 | |
| Domain | HSA | 5.35e-04 | 4 | 178 | 2 | PS51204 | |
| Domain | LRRC37AB_C | 5.35e-04 | 4 | 178 | 2 | PF14914 | |
| Domain | LRRC37_N | 5.35e-04 | 4 | 178 | 2 | IPR032754 | |
| Domain | LRRC37 | 5.35e-04 | 4 | 178 | 2 | PF15779 | |
| Domain | HSA_dom | 5.35e-04 | 4 | 178 | 2 | IPR014012 | |
| Domain | HSA | 5.35e-04 | 4 | 178 | 2 | PF07529 | |
| Domain | LRRC37A/B-like | 5.35e-04 | 4 | 178 | 2 | IPR015753 | |
| Domain | INTEGRASE | 8.86e-04 | 5 | 178 | 2 | PS50994 | |
| Domain | Integrase_cat-core | 8.86e-04 | 5 | 178 | 2 | IPR001584 | |
| Domain | fn3 | 9.37e-04 | 162 | 178 | 7 | PF00041 | |
| Domain | - | 1.19e-03 | 218 | 178 | 8 | 1.10.10.10 | |
| Domain | ZINC_FINGER_C2H2_1 | SP2 ZBTB2 SALL3 FOXP2 VEZF1 ZNF652 TUT7 ZNF280C ADNP2 ZNF831 CHAMP1 ZEB2 ZFHX4 GLI3 ZSCAN5C PLAGL1 FOXP1 | 1.25e-03 | 777 | 178 | 17 | PS00028 |
| Domain | SANT | 1.30e-03 | 50 | 178 | 4 | SM00717 | |
| Domain | zf-CCHC | 1.31e-03 | 23 | 178 | 3 | PF00098 | |
| Domain | Myb-like_dom | 1.32e-03 | 6 | 178 | 2 | IPR017877 | |
| Domain | SANT/Myb | 1.51e-03 | 52 | 178 | 4 | IPR001005 | |
| Domain | Znf_C2H2 | SP2 ZBTB2 SALL3 FOXP2 VEZF1 ZNF652 TUT7 ZNF280C ADNP2 ZNF831 CHAMP1 ZEB2 ZFHX4 GLI3 ZSCAN5C PLAGL1 FOXP1 | 1.82e-03 | 805 | 178 | 17 | IPR007087 |
| Domain | RNA_pol_II-bd | 1.84e-03 | 7 | 178 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.84e-03 | 7 | 178 | 2 | PF04818 | |
| Pubmed | TET2 HSPG2 SP2 TCF4 NCOA6 WBP11 EP400 FOXP2 VEZF1 SCAF8 BICRA MAML1 LARP1 PROSER1 SRCAP RFX7 ANKHD1 CHMP4B ZEB2 CIC EMSY SCAF4 GSE1 SATB1 ZFHX4 ATXN1 GLI3 SEC16A GMEB1 OTUD4 SMARCC2 FOXP1 IRF2BPL YY1AP1 HERC2 HERC1 TAF6 SRRM2 SAP130 MNT TP53BP1 MYB CBX2 | 2.86e-20 | 1429 | 189 | 43 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 FOXO3 HSPG2 NCOA6 EPPK1 BCL2L11 EP400 BICRA SREBF1 MAML1 HUWE1 SRCAP ANKHD1 WNK1 DENND1A CIC CCDC142 RABL6 ARAP3 PTPRS CASKIN1 TTLL4 SEC16A TNKS1BP1 MICAL3 RIC8A HERC2 HERC1 SNAPC4 MBD5 WNK2 CBX2 | 1.05e-14 | 1105 | 189 | 32 | 35748872 |
| Pubmed | FOXO3 SP2 TCF4 SALL3 GCM2 FOXP2 VEZF1 TUT7 ZNF280C SREBF1 SRCAP SKIL ATF6B CIC PPP1R10 TSC22D1 SATB1 ATXN1 GLI3 ZSCAN5C GMEB1 FOXP1 SNAPC4 TAF6 MNT MYB CBX2 | 5.46e-14 | 808 | 189 | 27 | 20412781 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO3 FOXN1 SP2 TCF4 GCM2 FOXP2 SOX30 SREBF1 ADNP2 RFX7 SKIL ATF6B ZEB2 CIC TSC22D1 USF3 DMRT3 FOXD4L1 SATB1 ZFHX4 GLI3 GMEB1 PLAGL1 FOXP1 SNAPC4 MNT MYB | 8.47e-13 | 908 | 189 | 27 | 19274049 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 EP400 RAPH1 SCAF8 LARP1 HUWE1 RFX7 POLR1G CHAMP1 CIC EMSY SCAF4 GSE1 SEC16A OTUD4 SMARCC2 IRF2BPL YY1AP1 TNKS1BP1 MICAL3 SNAPC4 TAF6 SRRM2 TP53BP1 SON | 1.07e-12 | 774 | 189 | 25 | 15302935 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXO3 FOXN1 TCF4 ZBTB2 EP400 STAG1 FOXP2 MAML1 LARP1 HUWE1 ANKHD1 SKIL ZEB2 CIC EMSY FOXD4L1 GSE1 SATB1 ZFHX4 SMARCC2 FOXP1 CDC27 SAP130 MNT TP53BP1 | 9.65e-12 | 857 | 189 | 25 | 25609649 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 NCOA6 EP400 FOXP2 BICRA MAML1 PROSER1 RFX7 ZEB2 EMSY GSE1 SATB1 ZFHX4 ATXN1 SEC16A SMARCC2 FOXP1 | 1.11e-11 | 351 | 189 | 17 | 38297188 |
| Pubmed | TANC2 ZBTB2 EP400 FOXP2 BICRA ADNP2 CHD9 SREK1 SRCAP POLR1G ANKHD1 SKIL CHAMP1 NCKAP5L GSE1 ZFHX4 ATXN1 GLI3 SEC16A SMARCC2 FOXP1 RIC8A LONRF3 TAF6 CDC27 SRRM2 SAP130 SON | 1.71e-11 | 1116 | 189 | 28 | 31753913 | |
| Pubmed | TANC2 WBP11 FOXP2 MAP6 HUWE1 ATF6B ZEB2 EMSY PTK2 NEDD4 FAM171A1 PLPPR4 PTPRS CASKIN1 SEC16A DCHS1 OTUD4 SMARCC2 RIMBP2 LRRC7 FRMPD3 HERC2 WNK3 WNK2 TP53BP1 TP53BP2 | 1.97e-11 | 963 | 189 | 26 | 28671696 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 MAGEL2 EPPK1 EP400 BICRA WNK1 CIC PTK2 NEDD4 USF3 SCN1A IRF2BPL IGSF9B SAP130 MEX3B WNK2 TP53BP2 SON | 2.97e-11 | 430 | 189 | 18 | 35044719 |
| Pubmed | 2.97e-10 | 104 | 189 | 10 | 9205841 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 SP2 EP400 VEZF1 BICRA ADNP2 MAML1 LARP1 NCKAP5L ZEB2 ZFHX4 SEC16A SMARCC2 FOXP1 YY1AP1 MYO15A | 6.99e-10 | 398 | 189 | 16 | 35016035 |
| Pubmed | EP400 SCAF8 ZEB2 NEDD4 KLHL29 PXDN GSE1 SEC16A OTUD4 RIMBP2 YY1AP1 MICAL3 LRRC7 SRRM2 PLXNB3 SON | 9.65e-10 | 407 | 189 | 16 | 12693553 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EP400 RAPH1 DSG1 ECD ZNF280C LARP1 SRCAP ANKHD1 CHMP4B WNK1 CHAMP1 CIC EMSY SCAF4 PPP1R10 GORASP2 GSE1 SEC16A TNKS1BP1 TAF6 TP53BP1 TP53BP2 SON | 1.83e-09 | 934 | 189 | 23 | 33916271 |
| Pubmed | TET2 NCOA6 WBP11 EP400 VEZF1 BICRA ZNF652 MAML1 LARP1 CHD9 CHMP4B ZEB2 CIC EMSY SCAF4 GSE1 GMEB1 SMARCC2 FOXP1 TAF6 SRRM2 SAP130 MNT TP53BP1 MYB | 1.83e-09 | 1103 | 189 | 25 | 34189442 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 FOXO3 TET2 NCOA6 RAPH1 LARP1 SRSF11 RFX7 WNK1 NCKAP5L DENND1A CIC NEDD4 FAM171A1 ATXN1 SEC16A TNKS1BP1 SRRM2 MEX3B WNK3 TP53BP2 OTOG | 2.16e-09 | 861 | 189 | 22 | 36931259 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NCOA6 WBP11 SALL3 EP400 VEZF1 BICRA ZNF280C LARP1 SRSF11 SREK1 CHAMP1 CIC EMSY SCAF4 PPP1R10 SEC16A SMARCC2 TAF6 SRRM2 SAP130 TP53BP1 SON CBX2 | 2.73e-09 | 954 | 189 | 23 | 36373674 |
| Pubmed | TET2 NCOA6 EP400 MAML1 SKIL CHAMP1 CIC EMSY GSE1 ATXN1 SMARCC2 FOXP1 SAP130 | 3.13e-09 | 268 | 189 | 13 | 33640491 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NCOA6 EP400 STAG1 SRCAP CHAMP1 EMSY PPP1R10 GSE1 SMARCC2 YY1AP1 TNKS1BP1 SRRM2 SAP130 TP53BP1 | 6.46e-09 | 341 | 189 | 14 | 32971831 |
| Pubmed | HSPG2 FAT4 WBP11 CRACR2A SREBF1 ANKHD1 WNK1 CIC GORASP2 FBLN2 ATXN1 NYNRIN SMARCC2 ROBO2 YY1AP1 RIC8A WNK2 TP53BP2 | 7.30e-09 | 608 | 189 | 18 | 16713569 | |
| Pubmed | CDCA3 NCOA6 EP400 STAG1 RAPH1 ZNF280C CHAMP1 CIC SCAF4 RIN1 SEC16A IRF2BPL SRRM2 SAP130 TP53BP1 TP53BP2 | 7.93e-09 | 472 | 189 | 16 | 38943005 | |
| Pubmed | 8.11e-09 | 28 | 189 | 6 | 29365100 | ||
| Pubmed | NCOA6 EP400 RAPH1 LARP1 HUWE1 SRCAP ANKHD1 CHAMP1 EMSY SCAF4 PPP1R10 SEC16A TNKS1BP1 TAF6 SAP130 TP53BP1 TP53BP2 | 1.01e-08 | 549 | 189 | 17 | 38280479 | |
| Pubmed | TET2 RAPH1 HUWE1 ANKHD1 CHAMP1 ZEB2 CIC GREB1L GSE1 SATB1 ZFHX4 SEC16A FOXP1 TNKS1BP1 TP53BP2 | 1.11e-08 | 418 | 189 | 15 | 34709266 | |
| Pubmed | 1.22e-08 | 152 | 189 | 10 | 38360978 | ||
| Pubmed | LARP1 HUWE1 POLR1G WNK1 CHAMP1 PPP1R10 RIN1 GORASP2 SEC16A GMEB1 OTUD4 TNKS1BP1 TAF6 SRRM2 TP53BP1 SON | 1.93e-08 | 503 | 189 | 16 | 16964243 | |
| Pubmed | TET2 NCOA6 EP400 ZNF280C MAML1 LARP1 ANKHD1 CHAMP1 NACAD PLPPR4 CASKIN1 TTLL4 SDC3 ROBO2 TNKS1BP1 WNK2 | 3.86e-08 | 529 | 189 | 16 | 14621295 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | STAG1 VEZF1 ZNF280C ADNP2 CHD9 SRCAP CHAMP1 ZEB2 CIC EMSY PPP1R10 SATB1 SMARCC2 HERC2 SNAPC4 CDC27 CBX2 | 4.45e-08 | 608 | 189 | 17 | 36089195 |
| Pubmed | CDCA3 WBP11 RAPH1 ZNF280C HUWE1 NCKAP5L CIC FAM171A1 PPP1R10 GORASP2 GSE1 PTPRK PTPRS SEC16A OTUD4 MICAL3 HERC2 HERC1 SRRM2 TP53BP2 CBX2 | 3.15e-07 | 1049 | 189 | 21 | 27880917 | |
| Pubmed | WBP11 BICRA LARP1 SRSF11 WNK1 SEC16A SMARCC2 FOXP1 TNKS1BP1 SRRM2 SAP130 TP53BP1 SON | 3.29e-07 | 399 | 189 | 13 | 35987950 | |
| Pubmed | 4.04e-07 | 12 | 189 | 4 | 14557543 | ||
| Pubmed | SP2 EP400 LARP1 CHD9 ZEB2 ZFHX4 GLI3 SEC16A SAP130 MAGEC2 CBX2 | 4.69e-07 | 282 | 189 | 11 | 23667531 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FOXO3 CABLES2 SCAF8 BICRA LARP1 CHD9 SRSF11 HUWE1 DENND1A PTK2 KLHL29 COL18A1 TSC22D1 USF3 PXDN ATXN1 PTPRS SDC3 FOXP1 MICAL3 LRRC7 IGSF9B MBD5 SAP130 WNK2 | 5.91e-07 | 1489 | 189 | 25 | 28611215 |
| Pubmed | WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. | 6.29e-07 | 4 | 189 | 3 | 11571656 | |
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 11498583 | ||
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 12588956 | ||
| Pubmed | 6.29e-07 | 4 | 189 | 3 | 34384519 | ||
| Pubmed | ZNF280C LARP1 SRSF11 ANKHD1 CHMP4B EMSY SCAF4 SEC16A TNKS1BP1 MICAL3 SRRM2 TP53BP1 | 7.43e-07 | 360 | 189 | 12 | 33111431 | |
| Pubmed | 8.03e-07 | 32 | 189 | 5 | 16516881 | ||
| Pubmed | HSPG2 NCOA6 STAG1 HUWE1 SKIL ZEB2 NEDD4 PPP1R10 GMEB1 PLAGL1 HERC2 HERC1 SAP130 TP53BP2 SON | 9.58e-07 | 591 | 189 | 15 | 15231748 | |
| Pubmed | FAT4 HUWE1 TRAPPC8 POLR1G RTN2 CIC SMARCC2 IRF2BPL TNKS1BP1 SRRM2 | 1.09e-06 | 246 | 189 | 10 | 15345747 | |
| Pubmed | 1.40e-06 | 101 | 189 | 7 | 10997877 | ||
| Pubmed | BICRA ADNP2 WNK1 NCKAP5L CIC PTK2 TSC22D1 USF3 ATXN1 YY1AP1 HERC2 MBD5 WNK2 | 2.94e-06 | 486 | 189 | 13 | 20936779 | |
| Pubmed | TANC2 SP2 ZBTB2 ZCCHC2 TRAPPC8 WNK1 SCAF4 TSC22D1 USF3 IRF2BPL MICAL3 MBD5 MEX3B | 3.43e-06 | 493 | 189 | 13 | 15368895 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 3.97e-06 | 167 | 189 | 8 | 20362541 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EP400 MAML1 HUWE1 ZCCHC2 SRCAP WNK1 NCKAP5L CIC EMSY GSE1 SEC16A YY1AP1 TNKS1BP1 TP53BP1 | 4.65e-06 | 588 | 189 | 14 | 38580884 |
| Pubmed | 5.44e-06 | 7 | 189 | 3 | 20525693 | ||
| Pubmed | 6.34e-06 | 83 | 189 | 6 | 28794006 | ||
| Pubmed | EP400 VEZF1 SCAF8 ZNF652 MAML1 SREK1 POLR1G ANKHD1 CHMP4B DENND1A CIC EMSY SCAF4 GREB1L PPP1R10 COL18A1 GORASP2 PXDN OTUD4 HERC2 TAF6 CDC27 SON | 7.48e-06 | 1497 | 189 | 23 | 31527615 | |
| Pubmed | 7.53e-06 | 130 | 189 | 7 | 19386638 | ||
| Pubmed | High-resolution photocatalytic mapping of SARS-CoV-2 spike interactions on the cell surface. | TET2 SCAF8 MAML1 DMRT3 GSE1 PTPRK SEC16A CCDC120 LONRF3 TP53BP2 | 7.77e-06 | 307 | 189 | 10 | 37499664 |
| Pubmed | 7.79e-06 | 183 | 189 | 8 | 36129980 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SP2 NCOA6 EP400 VEZF1 SREBF1 SRSF11 SRCAP RFX7 POLR1G SKIL CHAMP1 CIC EMSY SCAF4 PPP1R10 TAF6 CDC27 SRRM2 SAP130 MNT SON | 8.48e-06 | 1294 | 189 | 21 | 30804502 |
| Pubmed | 8.67e-06 | 8 | 189 | 3 | 23387299 | ||
| Pubmed | 8.67e-06 | 8 | 189 | 3 | 23838290 | ||
| Pubmed | SP2 TCF4 GCM2 FOXP2 VEZF1 TUT7 SREBF1 CHAMP1 RTN2 CIC FOXD4L1 SATB1 GLI3 GMEB1 MNT | 8.68e-06 | 709 | 189 | 15 | 22988430 | |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | FOXO3 SP2 TCF4 ZBTB2 GCM2 SOX30 SREBF1 RFX7 ATF6B DMRT3 GLI3 GMEB1 FOXP1 | 9.86e-06 | 544 | 189 | 13 | 28473536 |
| Pubmed | BCL2L11 PDGFRB ZNF652 TUT7 DAG1 PIDD1 SRSF11 CHAMP1 NCKAP5L GREB1L COL18A1 TSC22D1 PXDN PTPRS MICAL3 HERC2 MNT PCK2 OPLAH CBX2 | 1.15e-05 | 1215 | 189 | 20 | 15146197 | |
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.15e-05 | 26 | 189 | 4 | 26949039 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TANC2 CABLES2 STAG1 DSG1 SCAF8 PTK2 RABL6 CASKIN1 OTUD4 IGSF9B HERC2 TP53BP1 | 1.26e-05 | 475 | 189 | 12 | 31040226 |
| Pubmed | Perlecan maintains microvessel integrity in vivo and modulates their formation in vitro. | 1.30e-05 | 9 | 189 | 3 | 23320101 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EP400 DSG1 TUT7 ADNP2 HUWE1 SRCAP POLR1G ANKHD1 PTK2 RIN1 ARAP3 SEC16A SMARCC2 RIC8A HERC2 CDC27 SRRM2 PCK2 TP53BP1 TP53BP2 SON | 1.65e-05 | 1353 | 189 | 21 | 29467282 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.65e-05 | 203 | 189 | 8 | 22083510 | |
| Pubmed | 1.84e-05 | 10 | 189 | 3 | 20301505 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | EPPK1 EP400 LARP1 HUWE1 CHAMP1 CIC SATB1 ZFHX4 ATXN1 OTUD4 SAP130 TP53BP1 SON | 2.04e-05 | 583 | 189 | 13 | 29844126 |
| Pubmed | 2.08e-05 | 102 | 189 | 6 | 11214970 | ||
| Pubmed | 2.20e-05 | 103 | 189 | 6 | 32744500 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 2.27e-05 | 154 | 189 | 7 | 16055720 | |
| Pubmed | WBP11 EP400 RAPH1 SRSF11 SRCAP CIC SCAF4 SMARCC2 TAF6 SRRM2 TP53BP1 SON | 2.35e-05 | 506 | 189 | 12 | 30890647 | |
| Pubmed | 2.64e-05 | 64 | 189 | 5 | 22261194 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 30031127 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 28466777 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 36227108 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 2.94e-05 | 2 | 189 | 2 | 30104377 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 28427239 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 36977636 | ||
| Pubmed | ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. | 2.94e-05 | 2 | 189 | 2 | 17190598 | |
| Pubmed | Ten-eleven translocation 2 interacts with forkhead box O3 and regulates adult neurogenesis. | 2.94e-05 | 2 | 189 | 2 | 28660881 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 25422052 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 31104839 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 27856257 | ||
| Pubmed | The catalytic subunit of the SWR1 remodeler is a histone chaperone for the H2A.Z-H2B dimer. | 2.94e-05 | 2 | 189 | 2 | 24507717 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 24893771 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 30917032 | ||
| Pubmed | Metallothionein Protects the Heart Against Myocardial Infarction via the mTORC2/FoxO3a/Bim Pathway. | 2.94e-05 | 2 | 189 | 2 | 30860395 | |
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 2.94e-05 | 2 | 189 | 2 | 15056695 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 25853299 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 27224915 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 11358962 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 28741757 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 37573005 | ||
| Pubmed | Giant cadherins Fat and Dachsous self-bend to organize properly spaced intercellular junctions. | 2.94e-05 | 2 | 189 | 2 | 25355906 | |
| Pubmed | A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1. | 2.94e-05 | 2 | 189 | 2 | 25988806 | |
| Pubmed | Zac1 regulates cell cycle arrest in neuronal progenitors via Tcf4. | 2.94e-05 | 2 | 189 | 2 | 24396065 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 14527951 | ||
| Pubmed | WNK Inhibition Increases Surface Liquid pH and Host Defense in Cystic Fibrosis Airway Epithelia. | 2.94e-05 | 2 | 189 | 2 | 35849656 | |
| Pubmed | Stimulation of p53-mediated transcriptional activation by the p53-binding proteins, 53BP1 and 53BP2. | 2.94e-05 | 2 | 189 | 2 | 9748285 | |
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 33095160 | ||
| Pubmed | 2.94e-05 | 2 | 189 | 2 | 22539004 | ||
| Pubmed | 53BP1 is a haploinsufficient tumor suppressor and protects cells from radiation response in glioma. | 2.94e-05 | 2 | 189 | 2 | 22915756 | |
| Interaction | FEV interactions | SP2 NCOA6 EP400 FOXP2 VEZF1 BICRA MAML1 ZEB2 CIC EMSY GSE1 SATB1 ZFHX4 ATXN1 FOXP1 YY1AP1 TAF6 CBX2 | 3.59e-13 | 203 | 181 | 18 | int:FEV |
| Interaction | SP7 interactions | TET2 NCOA6 WBP11 EP400 SCAF8 BICRA MAML1 PROSER1 ZEB2 CIC SCAF4 GSE1 SATB1 ZFHX4 ATXN1 SMARCC2 FOXP1 SAP130 | 3.07e-10 | 304 | 181 | 18 | int:SP7 |
| Interaction | EGR2 interactions | TET2 NCOA6 EP400 FOXP2 BICRA MAML1 PROSER1 ZEB2 EMSY ZFHX4 ATXN1 SEC16A FOXP1 | 5.03e-09 | 171 | 181 | 13 | int:EGR2 |
| Interaction | TBXT interactions | NCOA6 MAML1 ZEB2 CIC GSE1 SATB1 ZFHX4 ATXN1 SMARCC2 FOXP1 SAP130 | 7.85e-09 | 116 | 181 | 11 | int:TBXT |
| Interaction | ERG interactions | TET2 NCOA6 BICRA MAML1 HUWE1 CIC EMSY NEDD4 GSE1 ZFHX4 ATXN1 SMARCC2 FOXP1 HERC2 | 1.49e-08 | 223 | 181 | 14 | int:ERG |
| Interaction | HNF1B interactions | TET2 EP400 BICRA MAML1 PROSER1 ZEB2 CIC GSE1 SATB1 ZFHX4 ATXN1 FOXP1 SAP130 | 1.79e-08 | 190 | 181 | 13 | int:HNF1B |
| Interaction | NFIX interactions | FOXN1 EP400 BICRA SRCAP ZEB2 CIC EMSY GSE1 ZFHX4 ATXN1 SMARCC2 FOXP1 TAF6 SAP130 | 1.87e-08 | 227 | 181 | 14 | int:NFIX |
| Interaction | TOP3B interactions | TANC2 FOXO3 HSPG2 NCOA6 EPPK1 BCL2L11 EP400 BICRA SREBF1 MAML1 HUWE1 SRCAP ANKHD1 WNK1 DENND1A CIC CCDC142 RABL6 GORASP2 ARAP3 PTPRS CASKIN1 TTLL4 SEC16A OTUD4 TNKS1BP1 MICAL3 RIC8A HERC2 HERC1 SNAPC4 MBD5 MEX3B WNK2 TP53BP1 CBX2 | 2.87e-08 | 1470 | 181 | 36 | int:TOP3B |
| Interaction | TLE3 interactions | TET2 TCF4 VEZF1 SCAF8 MAML1 PROSER1 CIC EMSY SCAF4 GSE1 ATXN1 OTUD4 SMARCC2 TNKS1BP1 SRRM2 SAP130 SON | 5.40e-08 | 376 | 181 | 17 | int:TLE3 |
| Interaction | PAX8 interactions | 6.27e-08 | 111 | 181 | 10 | int:PAX8 | |
| Interaction | ELK3 interactions | 1.32e-07 | 120 | 181 | 10 | int:ELK3 | |
| Interaction | HNF4A interactions | NCOA6 EP400 BICRA SREBF1 SRCAP ZEB2 CIC EMSY GSE1 ATXN1 SMARCC2 FOXP1 TAF6 SAP130 | 2.03e-07 | 275 | 181 | 14 | int:HNF4A |
| Interaction | KLF5 interactions | TET2 NCOA6 EP400 SREBF1 MAML1 LARP1 CIC NEDD4 GSE1 ATXN1 SEC16A FOXP1 | 2.05e-07 | 195 | 181 | 12 | int:KLF5 |
| Interaction | PAX6 interactions | NCOA6 GCM2 EP400 BICRA SRSF11 SRCAP ZEB2 CIC GSE1 SATB1 ZFHX4 ATXN1 SMARCC2 FOXP1 TAF6 SAP130 | 2.14e-07 | 366 | 181 | 16 | int:PAX6 |
| Interaction | PAX9 interactions | 2.80e-07 | 130 | 181 | 10 | int:PAX9 | |
| Interaction | NFYC interactions | 6.06e-07 | 177 | 181 | 11 | int:NFYC | |
| Interaction | EN1 interactions | 6.64e-07 | 110 | 181 | 9 | int:EN1 | |
| Interaction | PAX7 interactions | 1.82e-06 | 124 | 181 | 9 | int:PAX7 | |
| Interaction | MTA2 interactions | ZBTB2 BCL2L11 STAG1 C21orf58 POLR1G ZEB2 CIC RABL6 GSE1 SATB1 ATXN1 SMARCC2 TAF6 SRRM2 SAP130 TP53BP1 | 2.09e-06 | 435 | 181 | 16 | int:MTA2 |
| Interaction | SOX5 interactions | FOXP2 PROSER1 CIC GSE1 SATB1 ZFHX4 FOXP1 IRF2BPL TAF6 SAP130 | 2.12e-06 | 162 | 181 | 10 | int:SOX5 |
| Interaction | AR interactions | TET2 TCF4 NCOA6 EPPK1 EP400 SREBF1 MAML1 LARP1 HUWE1 DCC SRCAP SKIL CHAMP1 CIC EMSY GSE1 ATXN1 GLI3 SEC16A SMARCC2 FOXP1 IRF2BPL CDC27 SAP130 SON | 3.03e-06 | 992 | 181 | 25 | int:AR |
| Interaction | PPIA interactions | CDCA3 TCF4 NCOA6 SALL3 EP400 STAG1 RAPH1 ZNF280C HUWE1 SKIL SEC31B CHAMP1 CIC SCAF4 CDKL5 RIN1 SEC16A IRF2BPL SRRM2 SAP130 PCK2 TP53BP1 TP53BP2 | 5.00e-06 | 888 | 181 | 23 | int:PPIA |
| Interaction | TSC1 interactions | FOXO3 VEZF1 SREBF1 SAMD7 PTK2 NEDD4 RIN1 DMRT3 ATXN1 PTPRS CCDC120 WNK3 WNK2 TP53BP1 | 5.95e-06 | 366 | 181 | 14 | int:TSC1 |
| Interaction | TBR1 interactions | 8.31e-06 | 113 | 181 | 8 | int:TBR1 | |
| Interaction | SOX7 interactions | 9.05e-06 | 82 | 181 | 7 | int:SOX7 | |
| Interaction | KLF8 interactions | EP400 BICRA LARP1 ZEB2 CIC EMSY NEDD4 ATXN1 SEC16A FOXP1 TAF6 SAP130 MNT | 9.14e-06 | 329 | 181 | 13 | int:KLF8 |
| Interaction | TNIK interactions | TANC2 FOXP2 HUWE1 ZEB2 NEDD4 CDKL5 GSE1 PTPRS DCHS1 SMARCC2 RIMBP2 LRRC7 HERC2 TP53BP1 | 9.38e-06 | 381 | 181 | 14 | int:TNIK |
| Interaction | TERF2IP interactions | NCOA6 WBP11 ZBTB2 EP400 ZNF280C SRSF11 SREK1 SRCAP CHAMP1 CIC EMSY PPP1R10 SMARCC2 TAF6 SRRM2 SAP130 CBX2 | 1.06e-05 | 552 | 181 | 17 | int:TERF2IP |
| Interaction | PHIP interactions | 1.20e-05 | 197 | 181 | 10 | int:PHIP | |
| Interaction | SOX6 interactions | 1.26e-05 | 157 | 181 | 9 | int:SOX6 | |
| Interaction | KDM1A interactions | TET2 TCF4 EP400 RAPH1 ZNF280C HUWE1 TEX9 ANKHD1 CHAMP1 ZEB2 CIC GREB1L GSE1 SATB1 ZFHX4 ATXN1 SEC16A SMARCC2 FOXP1 TNKS1BP1 TAF6 TP53BP1 TP53BP2 | 1.28e-05 | 941 | 181 | 23 | int:KDM1A |
| Interaction | KLF15 interactions | SP2 EP400 VEZF1 MAML1 LARP1 CIC EMSY GSE1 SEC16A GMEB1 TAF6 SAP130 | 1.29e-05 | 290 | 181 | 12 | int:KLF15 |
| Interaction | GATA2 interactions | 1.32e-05 | 199 | 181 | 10 | int:GATA2 | |
| Interaction | CEBPA interactions | TET2 NCOA6 WBP11 EP400 STAG1 VEZF1 BICRA ZNF652 MAML1 LARP1 CHD9 CHMP4B ZEB2 CIC EMSY SCAF4 GSE1 GMEB1 SMARCC2 FOXP1 YY1AP1 TAF6 SRRM2 SAP130 MNT TP53BP1 MYB | 1.84e-05 | 1245 | 181 | 27 | int:CEBPA |
| Interaction | YWHAH interactions | TANC2 FOXO3 TET2 NCOA6 EPPK1 LARP1 HUWE1 RFX7 WNK1 NCKAP5L DENND1A CIC NEDD4 FAM171A1 RIN1 ATXN1 SEC16A TNKS1BP1 HERC1 SRRM2 MEX3B WNK3 WNK2 TP53BP2 OTOG | 1.85e-05 | 1102 | 181 | 25 | int:YWHAH |
| Interaction | CRX interactions | TET2 GCM2 EP400 FOXP2 BICRA MAML1 PROSER1 ZEB2 ZFHX4 ATXN1 FOXP1 | 1.96e-05 | 254 | 181 | 11 | int:CRX |
| Interaction | NAA40 interactions | EP400 RAPH1 DSG1 ECD ZNF280C LARP1 SRCAP ANKHD1 CHMP4B WNK1 CHAMP1 CIC EMSY SCAF4 PPP1R10 GORASP2 GSE1 SEC16A TNKS1BP1 TAF6 TP53BP1 TP53BP2 SON | 2.35e-05 | 978 | 181 | 23 | int:NAA40 |
| Interaction | VSX1 interactions | 2.81e-05 | 66 | 181 | 6 | int:VSX1 | |
| Interaction | SH3KBP1 interactions | RAPH1 PDGFRB DAG1 CHMP4B PTK2 NEDD4 CDKL5 ARAP3 TAF6 CDC27 SRRM2 TP53BP2 | 2.92e-05 | 315 | 181 | 12 | int:SH3KBP1 |
| Interaction | TLX1 interactions | 2.99e-05 | 175 | 181 | 9 | int:TLX1 | |
| Interaction | SMC5 interactions | NCOA6 WBP11 SALL3 EP400 VEZF1 BICRA ZNF280C LARP1 SRSF11 SREK1 CHAMP1 CIC EMSY SCAF4 PPP1R10 SEC16A SMARCC2 TAF6 SRRM2 SAP130 TP53BP1 SON CBX2 | 3.33e-05 | 1000 | 181 | 23 | int:SMC5 |
| Interaction | FOXP2 interactions | 3.93e-05 | 70 | 181 | 6 | int:FOXP2 | |
| Interaction | RCOR1 interactions | TCF4 RAPH1 HUWE1 ANKHD1 NCKAP5L ZEB2 CIC GSE1 SATB1 ZFHX4 SEC16A SMARCC2 TNKS1BP1 TP53BP1 TP53BP2 | 4.18e-05 | 494 | 181 | 15 | int:RCOR1 |
| Interaction | GTF2A1 interactions | 4.28e-05 | 104 | 181 | 7 | int:GTF2A1 | |
| Interaction | LHX3 interactions | 4.62e-05 | 185 | 181 | 9 | int:LHX3 | |
| Interaction | USP7 interactions | FOXO3 TET2 MAGEL2 SALL3 ZNF280C SREBF1 ADAMTS8 HUWE1 POLR1G CIC CDKL5 TSC22D1 ATXN1 FAM186A GLI3 NYNRIN OTUD4 SMARCC2 KLHDC7A HERC1 LONRF3 MED26 SRRM2 SAP130 MEX3B WNK3 CBX2 | 4.65e-05 | 1313 | 181 | 27 | int:USP7 |
| Interaction | H3-3A interactions | STAG1 VEZF1 ZNF280C ADNP2 CHD9 SRCAP CHAMP1 ZEB2 CIC EMSY NEDD4 PPP1R10 SATB1 SMARCC2 HERC2 SNAPC4 CDC27 SAP130 CBX2 | 4.66e-05 | 749 | 181 | 19 | int:H3-3A |
| Interaction | SMAD2 interactions | FOXO3 NCOA6 STAG1 HUWE1 SKIL ZEB2 NEDD4 RIN1 GLI3 SMARCC2 FOXP1 TAF6 CDC27 | 4.73e-05 | 385 | 181 | 13 | int:SMAD2 |
| Interaction | TNRC6A interactions | NCOA6 WNK1 HROB GLI3 NYNRIN SEC16A OTUD4 TNKS1BP1 CDC27 MEX3B TP53BP1 | 4.78e-05 | 280 | 181 | 11 | int:TNRC6A |
| Interaction | RBBP7 interactions | TET2 ZBTB2 EP400 STAG1 HUWE1 ANKHD1 ZEB2 CIC EMSY ARAP3 GSE1 ATXN1 SMARCC2 TAF6 SAP130 | 5.61e-05 | 507 | 181 | 15 | int:RBBP7 |
| Interaction | HDAC1 interactions | TET2 ZBTB2 EP400 STAG1 RAPH1 SREBF1 POLR1G ANKHD1 SKIL ZEB2 CIC EMSY GSE1 SATB1 ZFHX4 ATXN1 GLI3 SMARCC2 PLAGL1 TNKS1BP1 TAF6 SAP130 MNT TP53BP2 | 5.75e-05 | 1108 | 181 | 24 | int:HDAC1 |
| Interaction | RBBP4 interactions | ZBTB2 SALL3 STAG1 DSG1 HUWE1 CHMP4B CHAMP1 ZEB2 CIC EMSY GSE1 ATXN1 SMARCC2 TAF6 SRRM2 SAP130 | 6.27e-05 | 573 | 181 | 16 | int:RBBP4 |
| Interaction | SNRNP40 interactions | HSPG2 WBP11 EP400 VEZF1 DSG1 SCAF8 ECD ZNF280C ADNP2 SREK1 EMSY SCAF4 GSE1 SMARCC2 SRRM2 SON CBX2 | 6.43e-05 | 637 | 181 | 17 | int:SNRNP40 |
| Interaction | ZBTB10 interactions | 6.76e-05 | 151 | 181 | 8 | int:ZBTB10 | |
| Interaction | EYA4 interactions | 7.21e-05 | 243 | 181 | 10 | int:EYA4 | |
| Interaction | FOXL1 interactions | 7.22e-05 | 196 | 181 | 9 | int:FOXL1 | |
| Interaction | CTBP1 interactions | FOXO3 TCF4 EP400 FOXP2 MAML1 NCKAP5L ZEB2 CIC SATB1 ATXN1 SEC16A FOXP1 SRRM2 | 8.10e-05 | 406 | 181 | 13 | int:CTBP1 |
| Interaction | ELF4 interactions | 8.13e-05 | 115 | 181 | 7 | int:ELF4 | |
| Interaction | CREBBP interactions | FOXO3 NCOA6 ZBTB2 SREBF1 MAML1 HUWE1 SRCAP ATXN1 GLI3 GMEB1 SMARCC2 PLAGL1 CDC27 TP53BP1 TP53BP2 MYB | 1.05e-04 | 599 | 181 | 16 | int:CREBBP |
| Interaction | ETS1 interactions | 1.12e-04 | 121 | 181 | 7 | int:ETS1 | |
| Interaction | GOLGA2 interactions | NCOA6 CRACR2A PDGFRB SCAF8 BICRA ZNF280C TEX9 ANKHD1 CIC PTK2 SELENOV RIN1 GORASP2 GSE1 SEC16A CCDC120 FOXP1 SAP130 | 1.12e-04 | 733 | 181 | 18 | int:GOLGA2 |
| Interaction | MAGEA9 interactions | 1.14e-04 | 208 | 181 | 9 | int:MAGEA9 | |
| Interaction | YWHAB interactions | TANC2 FOXO3 TET2 BCL2L11 LARP1 TRAPPC8 RFX7 CHMP4B WNK1 NCKAP5L DENND1A CIC NEDD4 FAM171A1 RIN1 ATXN1 SRRM2 SAP130 MEX3B TP53BP2 OTOG SON | 1.17e-04 | 1014 | 181 | 22 | int:YWHAB |
| Interaction | TAF1 interactions | 1.26e-04 | 260 | 181 | 10 | int:TAF1 | |
| Interaction | EP300 interactions | FOXO3 TCF4 NCOA6 WBP11 SREBF1 MAML1 LARP1 SRSF11 SRCAP ITGAL ZEB2 SCAF4 NEDD4 RABL6 SATB1 SMARCC2 PLAGL1 RIC8A HERC1 TAF6 CDC27 SRRM2 PCK2 TP53BP1 TP53BP2 MYB SON | 1.38e-04 | 1401 | 181 | 27 | int:EP300 |
| Interaction | CDKN2AIPNL interactions | 1.64e-04 | 31 | 181 | 4 | int:CDKN2AIPNL | |
| Interaction | SPATA1 interactions | 1.64e-04 | 31 | 181 | 4 | int:SPATA1 | |
| Interaction | SIN3A interactions | TET2 SREBF1 SKIL CIC GSE1 SATB1 SMARCC2 TAF6 SAP130 MNT TP53BP1 MYB | 1.74e-04 | 380 | 181 | 12 | int:SIN3A |
| Interaction | SOX2 interactions | TET2 SP2 NCOA6 SALL3 EP400 TUT7 MAML1 LARP1 CHD9 PROSER1 ANKHD1 CHMP4B CHAMP1 ZEB2 CIC GSE1 SATB1 ZFHX4 ATXN1 GLI3 SEC16A SMARCC2 FOXP1 SLC45A2 SAP130 MAGEC2 CBX2 | 1.76e-04 | 1422 | 181 | 27 | int:SOX2 |
| Interaction | ZMYM2 interactions | 1.76e-04 | 271 | 181 | 10 | int:ZMYM2 | |
| Interaction | TOP1 interactions | NCOA6 ZBTB2 EP400 VEZF1 LARP1 SRSF11 SRCAP POLR1G CHMP4B CHAMP1 SCAF4 PPP1R10 SMARCC2 HERC2 SRRM2 SON CBX2 | 1.86e-04 | 696 | 181 | 17 | int:TOP1 |
| Interaction | TEAD1 interactions | 1.96e-04 | 176 | 181 | 8 | int:TEAD1 | |
| Interaction | PRPF40A interactions | HSPG2 WBP11 ZBTB2 SRSF11 SREK1 SCAF4 RABL6 PPP1R10 ATXN1 SMARCC2 HERC2 SRRM2 SON | 2.05e-04 | 446 | 181 | 13 | int:PRPF40A |
| Interaction | SMAD3 interactions | FOXO3 NCOA6 SKIL ZEB2 CIC NEDD4 GLI3 GMEB1 SMARCC2 PLAGL1 CDC27 SAP130 PCK2 | 2.10e-04 | 447 | 181 | 13 | int:SMAD3 |
| Interaction | KLF3 interactions | 2.26e-04 | 228 | 181 | 9 | int:KLF3 | |
| Interaction | ARF4 interactions | CDCA3 WBP11 ZBTB2 PDGFRB HUWE1 POLR1G CHMP4B DENND1A GORASP2 ATXN1 | 2.36e-04 | 281 | 181 | 10 | int:ARF4 |
| Interaction | CHMP4BP1 interactions | 2.39e-04 | 3 | 181 | 2 | int:CHMP4BP1 | |
| Interaction | TOX interactions | 2.41e-04 | 14 | 181 | 3 | int:TOX | |
| Interaction | RNGTT interactions | 2.42e-04 | 137 | 181 | 7 | int:RNGTT | |
| Interaction | YY1 interactions | FOXN1 EP400 FOXP2 SREBF1 SRCAP POLR1G CIC EMSY NEDD4 PPP1R10 FOXP1 TAF6 MYB | 2.44e-04 | 454 | 181 | 13 | int:YY1 |
| Interaction | FHL2 interactions | SP2 MAGEL2 EP400 SOX30 WNK1 EMSY ATXN1 FOXP1 YY1AP1 TNKS1BP1 SAP130 WNK3 | 2.53e-04 | 396 | 181 | 12 | int:FHL2 |
| Interaction | LHX2 interactions | 2.55e-04 | 183 | 181 | 8 | int:LHX2 | |
| Interaction | FOXP4 interactions | 2.57e-04 | 98 | 181 | 6 | int:FOXP4 | |
| Interaction | POU5F1 interactions | HSPG2 TCF4 ZBTB2 SALL3 EP400 SCAF8 HUWE1 EMSY NEDD4 PPP1R10 COL18A1 SMARCC2 SAP130 TP53BP1 CBX2 | 2.64e-04 | 584 | 181 | 15 | int:POU5F1 |
| Interaction | SOX13 interactions | 2.65e-04 | 35 | 181 | 4 | int:SOX13 | |
| Interaction | CLTB interactions | 2.74e-04 | 185 | 181 | 8 | int:CLTB | |
| Interaction | FOXQ1 interactions | 2.89e-04 | 141 | 181 | 7 | int:FOXQ1 | |
| Interaction | ACTL6A interactions | 2.95e-04 | 289 | 181 | 10 | int:ACTL6A | |
| Interaction | HDAC2 interactions | TET2 HSPG2 ZBTB2 EP400 STAG1 HUWE1 WNK1 ZEB2 CIC EMSY GSE1 SATB1 SMARCC2 TNKS1BP1 HERC2 TAF6 SRRM2 SAP130 PCK2 | 3.00e-04 | 865 | 181 | 19 | int:HDAC2 |
| Interaction | TLX3 interactions | 3.12e-04 | 291 | 181 | 10 | int:TLX3 | |
| Interaction | LAMA1 interactions | 3.17e-04 | 66 | 181 | 5 | int:LAMA1 | |
| Interaction | EMSY interactions | 3.42e-04 | 145 | 181 | 7 | int:EMSY | |
| Interaction | YWHAG interactions | TANC2 FOXO3 TET2 NCOA6 RAPH1 LARP1 SRSF11 HUWE1 RFX7 WNK1 NCKAP5L DENND1A CIC PTK2 NEDD4 FAM171A1 RIN1 ATXN1 SEC16A SRRM2 MEX3B TP53BP2 OTOG SON | 3.46e-04 | 1248 | 181 | 24 | int:YWHAG |
| Interaction | FMR1 interactions | ZBTB2 LARP1 EMSY NEDD4 FAM171A1 CDKL5 PLPPR4 CASKIN1 OTUD4 SMARCC2 HERC2 CDC27 MEX3B TP53BP1 | 3.59e-04 | 536 | 181 | 14 | int:FMR1 |
| Interaction | SMAD1 interactions | 3.62e-04 | 243 | 181 | 9 | int:SMAD1 | |
| Interaction | DAXX interactions | TCF4 ZBTB2 ZNF280C CHD9 CHMP4B CHAMP1 RABL6 PLAGL1 SRRM2 SAP130 CBX2 | 3.62e-04 | 353 | 181 | 11 | int:DAXX |
| Interaction | LUC7L2 interactions | LARP1 SRSF11 SREK1 HUWE1 ANKHD1 NEDD4 PPP1R10 ATXN1 HERC2 TAF6 SRRM2 | 3.62e-04 | 353 | 181 | 11 | int:LUC7L2 |
| Interaction | GCM1 interactions | 3.65e-04 | 68 | 181 | 5 | int:GCM1 | |
| Interaction | MEN1 interactions | NCOA6 EP400 STAG1 LARP1 SREK1 SRCAP POLR1G CHAMP1 EMSY PPP1R10 GSE1 SMARCC2 FOXP1 IRF2BPL YY1AP1 TNKS1BP1 SRRM2 SAP130 TP53BP1 MYB SON | 3.84e-04 | 1029 | 181 | 21 | int:MEN1 |
| Interaction | TAF10 interactions | 4.12e-04 | 107 | 181 | 6 | int:TAF10 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.27e-06 | 161 | 120 | 9 | 593 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.22e-04 | 15 | 120 | 3 | 529 | |
| GeneFamily | Forkhead boxes | 1.86e-04 | 43 | 120 | 4 | 508 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 4.20e-04 | 53 | 120 | 4 | 532 | |
| GeneFamily | Fibronectin type III domain containing | 6.96e-04 | 160 | 120 | 6 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.32e-03 | 181 | 120 | 6 | 694 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TANC2 RAPH1 MAP6 DCC RFX7 SEC31B CADM2 GSE1 ZFHX4 PLPPR4 PTPRK SCN1A CASKIN1 OTUD4 SDC3 SMARCC2 ROBO2 IRF2BPL RIMBP2 MICAL3 LRRC7 IGSF9B FRMPD3 HERC1 WNK3 | 1.90e-07 | 1106 | 181 | 25 | M39071 |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 1.39e-06 | 200 | 181 | 10 | M6095 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 CABLES2 NCOA6 FAT4 ECD ADNP2 CHD9 RFX7 ANKHD1 WNK1 NEDD4 YY1AP1 TNKS1BP1 CDC27 MNT | 1.50e-06 | 484 | 181 | 15 | MM999 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.82e-06 | 206 | 181 | 10 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.98e-06 | 208 | 181 | 10 | MM581 | |
| Coexpression | LAIHO_COLORECTAL_CANCER_SERRATED_DN | 2.09e-06 | 85 | 181 | 7 | M17423 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | FOXO3 STAG1 VEZF1 SCAF8 CHD9 TRAPPC8 ZEB2 PTK2 NEDD4 FAM171A1 GSE1 PTPRK ATXN1 OTUD4 MICAL3 CDC27 MNT TP53BP1 TP53BP2 SON | 2.14e-06 | 856 | 181 | 20 | M4500 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TET2 CABLES2 NCOA6 FAT4 ECD ADNP2 CHD9 RFX7 ANKHD1 WNK1 NEDD4 TNKS1BP1 CDC27 MNT | 4.96e-06 | 467 | 181 | 14 | M1347 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | CABLES2 HSPG2 EPPK1 PDGFRB SREBF1 DAG1 PROSER1 ATF6B FAM171A1 PPP1R10 PXDN PTPRK LRP10 PTPRS TTLL4 ABHD1 SON | 5.47e-06 | 681 | 181 | 17 | M5314 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 7.05e-06 | 189 | 181 | 9 | M3112 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | CABLES2 HSPG2 EPPK1 PDGFRB SREBF1 DAG1 PROSER1 ATF6B FAM171A1 PPP1R10 PXDN PTPRK LRP10 PTPRS TTLL4 ABHD1 SON | 8.29e-06 | 703 | 181 | 17 | MM1055 |
| Coexpression | GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | 1.11e-05 | 200 | 181 | 9 | M309 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_DN | 1.11e-05 | 200 | 181 | 9 | M6779 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | MAP6 SEC31B MAMDC4 ZEB2 CIC RABL6 COL18A1 PTPRS CCDC120 RIMBP2 LRRC7 SNAPC4 | 1.81e-05 | 389 | 181 | 12 | M39102 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | FOXO3 WBP11 ZBTB2 STAG1 SCAF8 ADNP2 SREK1 EMSY ARAP3 LRP10 ATXN1 FOXP1 LONRF3 SAP130 SLC26A6 SON | 2.16e-05 | 680 | 181 | 16 | M41089 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | FOXO3 TCF4 COL7A1 BCL2L11 SREBF1 CHD9 POLR1G SKIL CHMP4B PTK2 NEDD4 RIN1 TSC22D1 GSE1 PTPRK ATXN1 IRF2BPL MNT | 2.37e-05 | 843 | 181 | 18 | M2356 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 TET2 TCF4 FOXP2 MAP6 DCC SRCAP ANKHD1 SKIL RTN2 ZEB2 CADM2 SCAF4 KLHL29 TSC22D1 PXDN FOXP1 MICAL3 IGSF9B MEX3B PLXNB3 | 2.62e-05 | 1102 | 181 | 21 | M2369 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | TCF4 CD248 PDGFRB SREBF1 LARP1 ADAMTS8 DCC ROBO2 FOXP1 IRF2BPL MEX3B MYB | 3.10e-05 | 411 | 181 | 12 | M1351 |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN | TCF4 CD248 PDGFRB SREBF1 LARP1 ADAMTS8 DCC ROBO2 FOXP1 IRF2BPL MEX3B MYB | 3.48e-05 | 416 | 181 | 12 | MM1002 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | TANC2 TET2 TCF4 FOXP2 MAP6 DCC SRCAP ANKHD1 SKIL RTN2 ZEB2 CADM2 SCAF4 KLHL29 TSC22D1 PXDN FOXP1 MICAL3 IGSF9B MEX3B PLXNB3 | 3.50e-05 | 1124 | 181 | 21 | MM1070 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | MAP6 C21orf58 MAMDC4 NACAD FAM171A1 KIF19 DCHS1 SDC3 ROBO2 RIMBP2 MICAL3 WNK2 | 4.69e-05 | 429 | 181 | 12 | M45694 |
| Coexpression | PATIL_LIVER_CANCER | CABLES2 TCF4 COL7A1 PDGFRB ZNF652 MAML1 LARP1 WNK1 RTN2 PTK2 YY1AP1 TAF6 SLC26A6 TP53BP1 TP53BP2 | 5.81e-05 | 660 | 181 | 15 | M1195 |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 6.39e-05 | 194 | 181 | 8 | M3321 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 6.87e-05 | 196 | 181 | 8 | M5381 | |
| Coexpression | GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP | 7.38e-05 | 198 | 181 | 8 | M7050 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP | 7.64e-05 | 199 | 181 | 8 | M9255 | |
| Coexpression | GSE27786_LSK_VS_LIN_NEG_CELL_UP | 7.91e-05 | 200 | 181 | 8 | M4739 | |
| Coexpression | GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP | 7.91e-05 | 200 | 181 | 8 | M9258 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | FOXO3 STAG1 SCAF8 CHD9 TRAPPC8 PTK2 NEDD4 FAM171A1 PTPRK MICAL3 CDC27 TP53BP2 | 1.03e-04 | 466 | 181 | 12 | M13522 |
| Coexpression | NABA_CORE_MATRISOME | 1.32e-04 | 275 | 181 | 9 | M5884 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 1.58e-04 | 116 | 181 | 6 | M2379 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 1.61e-04 | 166 | 181 | 7 | M6826 | |
| Coexpression | IKEDA_MIR30_TARGETS_UP | 1.66e-04 | 117 | 181 | 6 | MM931 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.38e-04 | 177 | 181 | 7 | M39245 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TANC2 FOXP2 PDGFRB SKIL WNK1 ZEB2 PTPRK PTPRS GLI3 OTUD4 PLAGL1 FOXP1 HERC2 SON | 5.17e-06 | 385 | 179 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.12e-08 | 199 | 184 | 10 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.10e-06 | 186 | 184 | 8 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.29e-06 | 190 | 184 | 8 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-06 | 192 | 184 | 8 | 0b954a4e5857dac45d97c491af9b27cb2d1bd339 | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.45e-06 | 193 | 184 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-06 | 194 | 184 | 8 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 195 | 184 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.76e-06 | 198 | 184 | 8 | 0c8ec287500c58938ecc0dbbbc5f6c7a48733fc6 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.83e-06 | 199 | 184 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 1.83e-06 | 199 | 184 | 8 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | Control-Control-Others-HSPC|Control / Disease, condition lineage and cell class | 1.83e-06 | 199 | 184 | 8 | b71169be0d916b2ed139a3122d78bb154c71edb4 | |
| ToppCell | COVID-19-COVID-19_Mild-Others-HSPC|COVID-19_Mild / Disease, condition lineage and cell class | 1.83e-06 | 199 | 184 | 8 | 0230103c37ae3aff58240739b89f2c36b1e39a69 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-06 | 199 | 184 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.83e-06 | 199 | 184 | 8 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 169 | 184 | 7 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | Endothelial-A-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.55e-06 | 172 | 184 | 7 | a3201773a25832e92dd113fad165f1ecd37f5e91 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 8.77e-06 | 176 | 184 | 7 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.10e-06 | 177 | 184 | 7 | 36b5d29caa9cffbc0284f771a4db71aa72171a89 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC-HSPC|COVID-19_Mild / Disease group, lineage and cell class | 9.80e-06 | 179 | 184 | 7 | 19fcf48f5e02e4cb2b328efb4502f337e1282f72 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.80e-06 | 179 | 184 | 7 | 4bb2debfc9e9f258cd38e797ef160bd440aad6af | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.80e-06 | 179 | 184 | 7 | 2f690f933bf6b99abeb31766e0b22bdbe36c1ba0 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.80e-06 | 179 | 184 | 7 | 3e2c937369b8190fd5d5a31689d029e6e89fb5e2 | |
| ToppCell | COVID-19_Mild-Hematopoietic_SC|COVID-19_Mild / Disease group, lineage and cell class | 9.80e-06 | 179 | 184 | 7 | 50a073166e34bcfa52a62c4dafb3aef724e0fa8e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 181 | 184 | 7 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 181 | 184 | 7 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 181 | 184 | 7 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-05 | 181 | 184 | 7 | e7f7b519c2a01c15f26df11ec9b434c0d1630c7a | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.05e-05 | 181 | 184 | 7 | 54a19cf6a3b752e2391feb8b316bebee0e602d17 | |
| ToppCell | PBMC-Mild-Hematopoietic-HSPC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.05e-05 | 181 | 184 | 7 | 5b84625b1d3737708001b64f6da9360330d39a27 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 181 | 184 | 7 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 181 | 184 | 7 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.09e-05 | 182 | 184 | 7 | 6497eeafb2b137e70261ec0314782831892a940d | |
| ToppCell | Control-Hematopoietic_SC-HSPC|Control / Disease group, lineage and cell class | 1.09e-05 | 182 | 184 | 7 | 14e347c0e6444410f1948851407bb18c706569f4 | |
| ToppCell | Control-Hematopoietic_SC|Control / Disease group, lineage and cell class | 1.09e-05 | 182 | 184 | 7 | 43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 182 | 184 | 7 | d0ebf2f0d5370458ab81485a0017c311077133d5 | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-05 | 182 | 184 | 7 | bd1626261803324084fafca2f6665b50854e7fae | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 182 | 184 | 7 | 2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-05 | 182 | 184 | 7 | 918286422b3eab32d962b49aa07b1b9512e51d9d | |
| ToppCell | PBMC-Control-Hematopoietic-HSPC-HSPC|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-05 | 182 | 184 | 7 | 0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.35e-05 | 188 | 184 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 188 | 184 | 7 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-05 | 188 | 184 | 7 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-05 | 189 | 184 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 190 | 184 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.44e-05 | 190 | 184 | 7 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.49e-05 | 191 | 184 | 7 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.49e-05 | 191 | 184 | 7 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.54e-05 | 192 | 184 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 1.54e-05 | 192 | 184 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-05 | 192 | 184 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.60e-05 | 193 | 184 | 7 | 64edc1d6fb0fe117767d494cf4a5723bf8be2804 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 1.60e-05 | 193 | 184 | 7 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.65e-05 | 194 | 184 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.71e-05 | 195 | 184 | 7 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 184 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 195 | 184 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-05 | 196 | 184 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 196 | 184 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.82e-05 | 197 | 184 | 7 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 198 | 184 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.88e-05 | 198 | 184 | 7 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 198 | 184 | 7 | a699b365d3b6149f13f02b2e2ae9b6fdce761848 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.88e-05 | 198 | 184 | 7 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.94e-05 | 199 | 184 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.94e-05 | 199 | 184 | 7 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.94e-05 | 199 | 184 | 7 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.01e-05 | 200 | 184 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.01e-05 | 200 | 184 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.01e-05 | 200 | 184 | 7 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.01e-05 | 200 | 184 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 200 | 184 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Interneuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 200 | 184 | 7 | f5c63ef52bd7a898cf009b8bf9b2f7f4890d1c9b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-05 | 200 | 184 | 7 | 3dacd0afe69bc16bb33336ea9ea99a9cd47731d9 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.01e-05 | 200 | 184 | 7 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 200 | 184 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.27e-05 | 137 | 184 | 6 | 6d90da42dcc06aa895f920218055068f3c76d57d | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 145 | 184 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.51e-05 | 148 | 184 | 6 | d5cace5605bff2bb8248fadb51f2dad7539930ba | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK_CD56bright|World / disease group, cell group and cell class (v2) | 4.23e-05 | 153 | 184 | 6 | aff5c8ab1fb4ebc324cec02cf562b7484bb10db8 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 154 | 184 | 6 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.39e-05 | 154 | 184 | 6 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.55e-05 | 155 | 184 | 6 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.55e-05 | 155 | 184 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.71e-05 | 156 | 184 | 6 | 7e6805ebc7bc2f9c5965321d16922c155719970f | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-05 | 156 | 184 | 6 | ba9dfee9373d657d2a55572b41fc62001ad8b037 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-IPC_like-IPs_and_early_cortical_neurons|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.71e-05 | 156 | 184 | 6 | 741de05295b2d012ac8576378f37709a97c8fb50 | |
| ToppCell | Multiple_Sclerosis-Other-HSPC|Multiple_Sclerosis / Disease, Lineage and Cell Type | 6.22e-05 | 164 | 184 | 6 | 6af5529507d695b347adee4be5ead70f56c9cf55 | |
| ToppCell | metastatic_Brain-Myeloid_cells-pDCs|metastatic_Brain / Location, Cell class and cell subclass | 6.22e-05 | 164 | 184 | 6 | 06db4cc064f0765c481ce880207823872c27bfa9 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 6.88e-05 | 167 | 184 | 6 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.88e-05 | 167 | 184 | 6 | f4943fb5001475ddab82a0273bcbb3fa68fdd7bd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.88e-05 | 167 | 184 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-05 | 168 | 184 | 6 | 3fb79aaa858057c82645a90bd139fc4f096323c7 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 7.11e-05 | 168 | 184 | 6 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.35e-05 | 169 | 184 | 6 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.35e-05 | 169 | 184 | 6 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 171 | 184 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | remission-HSPC|remission / disease stage, cell group and cell class | 7.84e-05 | 171 | 184 | 6 | 41b424e58470a2fc25632aea50a37c7c5ea17645 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.10e-05 | 172 | 184 | 6 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| Drug | Thimerosal | TANC2 TET2 MAGEL2 EP400 STAG1 FOXP2 LRRC37A2 CHD9 DCC RFX7 WNK1 PTK2 CADM2 FBLN2 ARAP3 PTPRK ATXN1 NYNRIN OTUD4 SMARCC2 LRRC7 FRMPD3 CDC27 SRRM2 TAP2 TP53BP1 SON | 1.10e-06 | 1199 | 182 | 27 | ctd:D013849 |
| Drug | Nicergoline; Down 200; 8.2uM; HL60; HG-U133A | 4.41e-06 | 197 | 182 | 10 | 1374_DN | |
| Disease | Malignant neoplasm of breast | NCOA6 COL7A1 RAPH1 LRRC37A2 TRAPPC8 WNK1 MAMDC4 ZEB2 CIC EMSY NEDD4 ARAP3 LRRC37A RIC8A LRRC7 KLHDC7A HERC2 LONRF3 CDC27 MAGEC2 TP53BP1 TP53BP2 | 4.95e-07 | 1074 | 176 | 22 | C0006142 |
| Disease | feeling nervous measurement | 9.32e-07 | 87 | 176 | 7 | EFO_0009597 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | FOXO3 TET2 TCF4 STAG1 FOXP2 DCC ZEB2 CADM2 ATXN1 FOXP1 IGSF9B MED26 | 1.26e-06 | 346 | 176 | 12 | EFO_0004337, EFO_0004784, MONDO_0005090 |
| Disease | corneal resistance factor | TET2 TCF4 STAG1 ADAMTS8 MAMDC4 CIC NEDD4 FBLN2 ATXN1 GLI3 FOXP1 HERC2 CDC27 | 3.48e-06 | 451 | 176 | 13 | EFO_0010067 |
| Disease | pseudohypoaldosteronism (implicated_via_orthology) | 4.12e-06 | 6 | 176 | 3 | DOID:4479 (implicated_via_orthology) | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 1.93e-05 | 27 | 176 | 4 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | Neurodevelopmental Disorders | 2.05e-05 | 93 | 176 | 6 | C1535926 | |
| Disease | Colorectal Carcinoma | TET2 COL7A1 SALL3 CD248 DCC WNK1 ZEB2 CDKL5 FBLN2 ARAP3 GSE1 PTPRS GLI3 NPAP1 DCHS1 | 2.22e-05 | 702 | 176 | 15 | C0009402 |
| Disease | PRADER-WILLI SYNDROME | 2.43e-05 | 10 | 176 | 3 | 176270 | |
| Disease | Prader-Willi syndrome | 2.43e-05 | 10 | 176 | 3 | cv:C0032897 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | FOXO3 TET2 TCF4 FOXP2 DCC DENND1A PTK2 CADM2 SCAF4 KLHL29 PTPRK POM121L12 ROBO2 FOXP1 IGSF9B HERC1 | 2.66e-05 | 801 | 176 | 16 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | brain connectivity measurement | FOXO3 FOXP2 LRRC37A2 ADAMTS8 NEDD4 DMRT3 GLI3 ROBO2 FOXP1 CDC27 WNK2 | 3.08e-05 | 400 | 176 | 11 | EFO_0005210 |
| Disease | Van Maldergem Wetzburger Verloes syndrome | 3.54e-05 | 2 | 176 | 2 | C1832390 | |
| Disease | Van Maldergem syndrome | 3.54e-05 | 2 | 176 | 2 | cv:C1832390 | |
| Disease | Periventricular gray matter heterotopia | 3.54e-05 | 2 | 176 | 2 | C1849173 | |
| Disease | Royer Syndrome | 4.41e-05 | 12 | 176 | 3 | C0265222 | |
| Disease | obesity (implicated_via_orthology) | 4.76e-05 | 215 | 176 | 8 | DOID:9970 (implicated_via_orthology) | |
| Disease | Prader-Willi Syndrome | 5.71e-05 | 13 | 176 | 3 | C0032897 | |
| Disease | actinic keratosis | 7.24e-05 | 14 | 176 | 3 | EFO_0002496 | |
| Disease | testosterone measurement | TET2 NCOA6 BCL2L11 STAG1 ZNF652 TUT7 DAG1 SRCAP POLR1G CHAMP1 ZFHX4 FAM186A NYNRIN PLAGL1 FOXP1 RIMBP2 YY1AP1 TNKS1BP1 ATP12A MYO15A | 7.98e-05 | 1275 | 176 | 20 | EFO_0004908 |
| Disease | Intellectual Disability | TANC2 STAG1 PDGFRB DCC CHAMP1 CIC RABL6 COL18A1 SCN1A SMARCC2 TAF6 | 8.33e-05 | 447 | 176 | 11 | C3714756 |
| Disease | feeling "fed-up" measurement | 9.36e-05 | 76 | 176 | 5 | EFO_0009588 | |
| Disease | Heterotopia, Periventricular, Autosomal Recessive | 1.06e-04 | 3 | 176 | 2 | C1842563 | |
| Disease | autism spectrum disorder (is_implicated_in) | 1.10e-04 | 16 | 176 | 3 | DOID:0060041 (is_implicated_in) | |
| Disease | neuroticism measurement, cognitive function measurement | FOXO3 TET2 STAG1 FOXP2 CD248 DCC DENND1A CADM2 KLHL29 PTPRK FOXP1 IGSF9B | 1.61e-04 | 566 | 176 | 12 | EFO_0007660, EFO_0008354 |
| Disease | Profound Mental Retardation | 1.93e-04 | 139 | 176 | 6 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 1.93e-04 | 139 | 176 | 6 | C0025363 | |
| Disease | Mental deficiency | 1.93e-04 | 139 | 176 | 6 | C0917816 | |
| Disease | non-melanoma skin carcinoma | 2.02e-04 | 265 | 176 | 8 | EFO_0009260 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.10e-04 | 49 | 176 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | suntan, skin pigmentation | 2.11e-04 | 4 | 176 | 2 | EFO_0003784, EFO_0004279 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 2.11e-04 | 4 | 176 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | myeloproliferative neoplasm (is_implicated_in) | 2.11e-04 | 4 | 176 | 2 | DOID:2226 (is_implicated_in) | |
| Disease | Adenoid Cystic Carcinoma | 3.40e-04 | 100 | 176 | 5 | C0010606 | |
| Disease | Paroxysmal atrial fibrillation | 3.59e-04 | 156 | 176 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 3.59e-04 | 156 | 176 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.59e-04 | 156 | 176 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 4.11e-04 | 160 | 176 | 6 | C0004238 | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 4.60e-04 | 60 | 176 | 4 | C4722327 | |
| Disease | brain measurement, neuroimaging measurement | FOXO3 TCF4 FOXP2 ADAMTS8 DCC PTK2 COL18A1 CARF ROBO2 FOXP1 WNK2 | 4.93e-04 | 550 | 176 | 11 | EFO_0004346, EFO_0004464 |
| Disease | household income | 5.05e-04 | 304 | 176 | 8 | EFO_0009695 | |
| Disease | clinical depression | 5.22e-04 | 6 | 176 | 2 | C2362914 | |
| Disease | Leukemia, Myelomonocytic, Chronic | 5.22e-04 | 6 | 176 | 2 | C0023480 | |
| Disease | disease prognosis measurement | 5.22e-04 | 6 | 176 | 2 | EFO_0007936 | |
| Disease | risky sexual behaviour measurement | 5.48e-04 | 169 | 176 | 6 | EFO_0007877 | |
| Disease | central corneal thickness | 5.62e-04 | 309 | 176 | 8 | EFO_0005213 | |
| Disease | taste liking measurement | 5.66e-04 | 388 | 176 | 9 | EFO_0010155 | |
| Disease | eosinophil count | TET2 BCL2L11 ZNF652 SREBF1 WNK1 NACAD ATF6B EMSY TNFRSF4 PXDN GSE1 ATXN1 SEC16A SDC3 PLAGL1 FOXP1 TNKS1BP1 MBD5 TP53BP1 MYB | 5.97e-04 | 1488 | 176 | 20 | EFO_0004842 |
| Disease | squamous cell carcinoma | 7.00e-04 | 67 | 176 | 4 | EFO_0000707 | |
| Disease | cancer | 7.03e-04 | 400 | 176 | 9 | MONDO_0004992 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 7.40e-04 | 68 | 176 | 4 | EFO_0007826, EFO_0007860 | |
| Disease | melanoma | 7.52e-04 | 248 | 176 | 7 | C0025202 | |
| Disease | Prostate cancer, familial | 7.82e-04 | 69 | 176 | 4 | C2931456 | |
| Disease | prostate carcinoma | TANC2 TET2 TCF4 WBP11 SALL3 BCL2L11 ZNF652 RFX7 SKIL EMSY NEDD4 SDC3 FOXP1 WNK3 | 9.59e-04 | 891 | 176 | 14 | EFO_0001663 |
| Disease | Primary sclerosing cholangitis | 9.67e-04 | 8 | 176 | 2 | C0566602 | |
| Disease | drug use measurement | 9.67e-04 | 8 | 176 | 2 | EFO_0007010 | |
| Disease | basal cell carcinoma | 9.83e-04 | 189 | 176 | 6 | EFO_0004193 | |
| Disease | mean corpuscular hemoglobin concentration | BCL2L11 EP400 LRRC37A2 DAG1 LARP1 TEX9 ZEB2 KLHL29 ATXN1 SEC16A OTUD4 FOXP1 RIC8A MYO15A MEX3B MYB | 9.96e-04 | 1105 | 176 | 16 | EFO_0004528 |
| Disease | cutaneous squamous cell carcinoma | 9.98e-04 | 33 | 176 | 3 | EFO_1001927 | |
| Disease | retinal vasculature measurement | CDCA3 HSPG2 TCF4 PDGFRB DCC KLHL29 PXDN SLC45A2 RIMBP2 HERC2 | 1.14e-03 | 517 | 176 | 10 | EFO_0010554 |
| Disease | Corneal astigmatism | 1.18e-03 | 77 | 176 | 4 | EFO_1002040 | |
| Disease | granulocyte percentage of myeloid white cells | 1.18e-03 | 268 | 176 | 7 | EFO_0007997 | |
| Disease | uveitis | 1.24e-03 | 9 | 176 | 2 | EFO_1001231 | |
| Disease | irritability measurement | 1.49e-03 | 82 | 176 | 4 | EFO_0009594 | |
| Disease | Breast Carcinoma | COL7A1 LRRC37A2 ZEB2 EMSY LRRC37A RIC8A KLHDC7A HERC2 TP53BP1 TP53BP2 | 1.53e-03 | 538 | 176 | 10 | C0678222 |
| Disease | hair colour measurement, eye colour measurement, skin pigmentation measurement | 1.54e-03 | 10 | 176 | 2 | EFO_0007009, EFO_0007822, EFO_0009764 | |
| Disease | nephritis (implicated_via_orthology) | 1.54e-03 | 10 | 176 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | smoking status measurement | FOXO3 FOXP2 BICRA DCC PTK2 CADM2 KLHL29 PTPRK POM121L12 GMEB1 ROBO2 FOXP1 IRF2BPL IGSF9B HERC1 PCK2 | 1.64e-03 | 1160 | 176 | 16 | EFO_0006527 |
| Disease | atrial fibrillation | 1.81e-03 | 371 | 176 | 8 | EFO_0000275 | |
| Disease | pigmentation disease (is_implicated_in) | 1.88e-03 | 11 | 176 | 2 | DOID:10123 (is_implicated_in) | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 1.93e-03 | 88 | 176 | 4 | EFO_0000341, EFO_0006527 | |
| Disease | hair colour measurement, hair morphology measurement | 2.24e-03 | 12 | 176 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | worry measurement | 2.36e-03 | 154 | 176 | 5 | EFO_0009589 | |
| Disease | fibrinogen measurement, coronary artery disease | 2.36e-03 | 154 | 176 | 5 | EFO_0001645, EFO_0004623 | |
| Disease | social interaction measurement | 2.46e-03 | 94 | 176 | 4 | EFO_0009592 | |
| Disease | white matter microstructure measurement | 2.46e-03 | 390 | 176 | 8 | EFO_0005674 | |
| Disease | Craniofacial Abnormalities | 2.49e-03 | 156 | 176 | 5 | C0376634 | |
| Disease | multisite chronic pain | 2.55e-03 | 95 | 176 | 4 | EFO_0010100 | |
| Disease | disorder of pharynx | 2.62e-03 | 46 | 176 | 3 | MONDO_0020592 | |
| Disease | biological sex | 2.65e-03 | 230 | 176 | 6 | PATO_0000047 | |
| Disease | sexual dimorphism measurement | FOXO3 TET2 NCOA6 COL7A1 EPPK1 CD248 TUT7 KLHL29 HROB NYNRIN CASKIN1 SEC16A OTUD4 HERC1 TP53BP1 | 2.68e-03 | 1106 | 176 | 15 | EFO_0021796 |
| Disease | cortical thickness | FOXO3 HSPG2 TCF4 FOXP2 SREBF1 ADAMTS8 DENND1A KLHL29 COL18A1 DMRT3 GLI3 ROBO2 FOXP1 MICAL3 WNK2 | 2.85e-03 | 1113 | 176 | 15 | EFO_0004840 |
| Disease | lifestyle measurement | 2.95e-03 | 235 | 176 | 6 | EFO_0010724 | |
| Disease | circadian rhythm | 3.01e-03 | 163 | 176 | 5 | EFO_0004354 | |
| Disease | neuroticism measurement | TCF4 STAG1 FOXP2 DAG1 DCC ATF6B PTK2 CADM2 KLHL29 IGSF9B HERC1 MBD5 TAP2 | 3.28e-03 | 909 | 176 | 13 | EFO_0007660 |
| Disease | suntan | 3.42e-03 | 103 | 176 | 4 | EFO_0004279 | |
| Disease | lung adenocarcinoma, family history of lung cancer | 3.52e-03 | 51 | 176 | 3 | EFO_0000571, EFO_0006953 | |
| Disease | generalised epilepsy | 3.72e-03 | 52 | 176 | 3 | EFO_0005917 | |
| Disease | central nervous system disease (implicated_via_orthology) | 4.02e-03 | 16 | 176 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | nervousness | 4.02e-03 | 16 | 176 | 2 | NCIT_C74532 | |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 4.02e-03 | 16 | 176 | 2 | C0393706 | |
| Disease | depressive symptom measurement | 4.20e-03 | 426 | 176 | 8 | EFO_0007006 | |
| Disease | Mammary Carcinoma, Human | COL7A1 LRRC37A2 ZEB2 EMSY LRRC37A RIC8A KLHDC7A TP53BP1 TP53BP2 | 4.43e-03 | 525 | 176 | 9 | C4704874 |
| Disease | Mammary Neoplasms, Human | COL7A1 LRRC37A2 ZEB2 EMSY LRRC37A RIC8A KLHDC7A TP53BP1 TP53BP2 | 4.43e-03 | 525 | 176 | 9 | C1257931 |
| Disease | pathological myopia | 4.46e-03 | 111 | 176 | 4 | EFO_0004207 | |
| Disease | urinary albumin to creatinine ratio | 4.48e-03 | 179 | 176 | 5 | EFO_0007778 | |
| Disease | iritis | 4.54e-03 | 17 | 176 | 2 | EFO_1000997 | |
| Disease | response to homoharringtonine, cytotoxicity measurement | 4.54e-03 | 17 | 176 | 2 | EFO_0006952, EFO_0006996 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 4.54e-03 | 17 | 176 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Mammary Neoplasms | COL7A1 LRRC37A2 ZEB2 EMSY LRRC37A RIC8A KLHDC7A TP53BP1 TP53BP2 | 4.54e-03 | 527 | 176 | 9 | C1458155 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VSEVSTLQPLPPGPR | 426 | Q6UXC1 | |
| NQQITLAPLPLPSPT | 86 | Q96L91 | |
| TPPIFGPLTTQTTIP | 146 | Q9N2K0 | |
| TPPIFGPLTTQTTIP | 146 | Q9N2J8 | |
| QPQDIVCLGVSPPPT | 731 | Q8WWN8 | |
| PLPEPLTVQLLTVPG | 781 | Q9UP79 | |
| PLVTTLGAQLPPQAP | 556 | Q9HCU0 | |
| VNPLTPSPLNGALVP | 26 | Q14687 | |
| KQPIGQIPLESSPPV | 4771 | Q6V0I7 | |
| NVPSPIGEIQPLSPQ | 291 | Q8IZP9 | |
| IGEIQPLSPQPSAPI | 296 | Q8IZP9 | |
| PQLRPGAPTSLQTEP | 26 | O43521 | |
| QGQIPEAPPLKLTPT | 506 | Q9BSW2 | |
| SLEPPLQPGTSPAQT | 686 | Q17RM4 | |
| LEISGPETVPLPNVP | 181 | Q9H444 | |
| LEVSGPETVPLPNVP | 141 | P59074 | |
| SFIPSQLIPPTANPV | 141 | P54253 | |
| PTTPPTIPQALNIIT | 161 | O95905 | |
| PAGQQPRVLLSPSIP | 546 | Q13625 | |
| SPLPVGQNSLTLQPP | 336 | Q6IQ32 | |
| QTAPSRVLPPGQTAP | 491 | Q6IQ32 | |
| RTPIQVESSPQPGLP | 36 | Q99618 | |
| SVKPQILVPPNGVVP | 696 | Q70E73 | |
| PTGVPAPIPVLSVTQ | 606 | Q01804 | |
| PGTPPLSSTQLQIDP | 561 | P98160 | |
| PVVSIHPPQLTVQPG | 1866 | P98160 | |
| PLPAGPVPSQDITLS | 456 | Q3YEC7 | |
| SLVPPGQEQNPSSVP | 571 | Q92585 | |
| TIRENAPPGTPIVSP | 2076 | Q96JQ0 | |
| VLTQPVPKLQGSPTP | 1231 | Q8WXD9 | |
| PIKVATQPELQVPGP | 516 | P43146 | |
| ALPPVLTTVNGQSPP | 131 | Q6PKG0 | |
| SPPIPGPVVTQDITT | 286 | Q5VUB5 | |
| QPVTLPEARTPVSPG | 1226 | Q7RTP6 | |
| TFPTQRPIPGIPTVL | 386 | P10071 | |
| PPSPLQLPGGNVTIT | 101 | Q7Z4F1 | |
| IPNLTESIPSSPPQG | 76 | Q9UBF1 | |
| PVLVKDQGPTVLQPP | 721 | Q96JE9 | |
| TQGPRDPQLPTVSPL | 781 | Q96JE9 | |
| SGPQAEVPTLPLQPS | 671 | Q9UJ55 | |
| VLSTGVPTVPLLPPQ | 271 | Q9H8Y8 | |
| VPTVPLLPPQVNQSL | 276 | Q9H8Y8 | |
| LLPPQVNQSLTSVPP | 281 | Q9H8Y8 | |
| TQPPDLGLAIIPEPT | 746 | A6NM11 | |
| TQPPDLGLAIIPEPT | 746 | A6NMS7 | |
| QPTLPVLLPTSSGLP | 756 | P46934 | |
| TTGSLPQIPLTPLQP | 111 | Q9HCH0 | |
| LSPSPPVQQPQFTVI | 391 | Q9Y692 | |
| LAPVPVSPQSPNLLT | 976 | Q6PRD1 | |
| PLPIQIPSSQATRGP | 1411 | Q96NW7 | |
| QLLGPVPSPTLQPED | 966 | Q9UKN7 | |
| PVPLQTITNENPSGP | 1761 | O95714 | |
| GPNSLTPPKQTPEIV | 91 | P54707 | |
| QVPVPQLPVQSATSP | 471 | P15884 | |
| NSLPTGVAPNLPTIP | 2376 | Q2LD37 | |
| SVPLQLGLPDTVPPQ | 4371 | Q15751 | |
| PLLGPLQPLSSNTPI | 191 | Q8N187 | |
| VTAIGPPTTAIQEPP | 321 | Q14118 | |
| LPLPQPLPLSTGSVI | 176 | Q96HB5 | |
| SQVASNTIPLPLPQP | 666 | P98095 | |
| TVPPNLLPQTLLNGP | 251 | Q9H1B7 | |
| IVTPSQRDTVPLPPG | 111 | Q16822 | |
| PSPIAGRQPLEVQPL | 376 | Q9ULL4 | |
| LVQSLPTGPTIPQPL | 281 | A6NMU1 | |
| AATTIPEPQGPLPVQ | 41 | P39060 | |
| PITQGPSVITPASVP | 456 | O15409 | |
| TIQPGQPALPLQPLA | 206 | Q9H334 | |
| PGTTQPPSPQLLRND | 271 | P0CG43 | |
| LTVIPIPVVTNSPQP | 86 | Q99583 | |
| PRIPLQPQAPVSSIG | 336 | Q8N3J3 | |
| APPTAQLPATGQPTV | 226 | P10242 | |
| PLPSPVTNGTSPAQL | 251 | Q15599 | |
| PVTIGIAPPERQESP | 136 | Q8N7R1 | |
| SAPVPQTPLTGILQP | 361 | Q9C091 | |
| QTPLTGILQPRPIPA | 366 | Q9C091 | |
| TPPALGEVPQELQSP | 2776 | Q7Z6Z7 | |
| DPLVPNSSPLPTNGI | 171 | O95402 | |
| GPQPEPRDITTVIPQ | 601 | Q02413 | |
| PEPKEVNGIPPTTTQ | 666 | Q13332 | |
| LPPTSQGLSNPTPVI | 436 | Q86XN7 | |
| PTPPPIQLGSLVTQE | 726 | Q2TAC6 | |
| GIRPQFTAPTQVPVP | 301 | Q14686 | |
| TSPLPAGQVPVTLQP | 181 | P62683 | |
| TSPLPAGQVPVTLQP | 181 | P63145 | |
| TSPLPAGQVPVTLQP | 181 | Q7LDI9 | |
| TSPLPAGQVPVTLQP | 181 | P62685 | |
| TSPLPAGQVPVTLQP | 181 | P63126 | |
| TSPLPAGQVPVTLQP | 181 | P62684 | |
| QPQGIPDTESPVPVI | 2476 | Q3L8U1 | |
| TVSPPPVVTQLPNIP | 776 | Q6WRI0 | |
| PVGSLVPTLEQPQVP | 21 | A4D1S0 | |
| PGPQPAPTQELSLQV | 341 | Q14781 | |
| QEAPVSSGPLLSPVP | 731 | Q5SW24 | |
| LPTVPQPPATIIQQL | 201 | P58505 | |
| SSNVVPSPLAGPLQP | 346 | Q9NQL9 | |
| PQKPGSVVSPELQTP | 156 | Q96JM3 | |
| PPPPQTAGLIVLATI | 781 | Q5JV73 | |
| LPVPQGILFTTPSPS | 301 | Q6P531 | |
| IIPSTPFPQEGQPLI | 231 | Q8N3J6 | |
| PGLTALPENPNTTLP | 1036 | Q9P267 | |
| VVPQGPTELLQPLSP | 756 | Q8TEH3 | |
| ISELQPSLPPGSLQP | 186 | Q17RN3 | |
| TPGTLPVLQPSLGPQ | 291 | Q9NU39 | |
| PQGTLLPTVLTLPTP | 756 | Q5VTJ3 | |
| PTGPELPVSPVTDLQ | 501 | Q02388 | |
| QQSPLPPGIKPTIQI | 436 | Q7Z589 | |
| LSPGQPLVPEASSIP | 1856 | A6NE01 | |
| QAPPAVSTPLPLGLQ | 626 | Q9NZM4 | |
| SLQLLSPQPGEQLPP | 641 | O76039 | |
| PAVLPTTNIQPVGTP | 111 | O75056 | |
| NLPTPPVTQPVSLLG | 816 | O95104 | |
| PVTPVTPANVVQGLP | 161 | Q9UPN6 | |
| TVPTSVGLQLPPTVP | 521 | Q9BXA9 | |
| PLTEVAKGIPPQQTP | 241 | Q9UMX9 | |
| QVLSPTITSPPNALP | 361 | P30260 | |
| RTPAPQGLLSPTQVP | 96 | Q9BTV7 | |
| EPQISQGLVVTPPGP | 26 | P09619 | |
| PVTVQLPLPSGITGL | 531 | Q9HB75 | |
| PAVPVAGPPQTVSNL | 536 | Q15262 | |
| LPQIGPPLTSTPQLQ | 476 | Q9P2P1 | |
| PVVSPGPTQTTLQQP | 1531 | Q6ZRI0 | |
| VPGPPNLPGQTTIQV | 151 | Q6ZN04 | |
| LDNITLPPSQPSPTG | 391 | O43524 | |
| QPSSPEVLTPQLSPG | 196 | O75298 | |
| QPRPTLTLSQAPQPG | 486 | P49848 | |
| PPAPPQDVTVQAGVT | 486 | O15034 | |
| SPSRILPQPQGTPVS | 651 | O15034 | |
| PVPVLPGAVPSQTER | 266 | Q13671 | |
| TVSLGQLPLPPIPHV | 431 | Q9UM63 | |
| GSPQPLATTPLSQEP | 376 | Q9UQ35 | |
| SPQVLPGPLLIPSDS | 126 | P12757 | |
| LLTPTGQQTIPLIPS | 6 | Q7Z3H4 | |
| IPAGLVPPVAPNTQL | 326 | Q9BXS9 | |
| PGTVGPQLDPIQLSI | 726 | O14841 | |
| GVKLQPQEISPPPTA | 901 | Q05397 | |
| PPQSDVTLPGPTRLE | 6 | O15353 | |
| TPPPGAPALQTVITT | 371 | O75603 | |
| LPPLPVPGTNSTEQA | 6 | P58107 | |
| PQQSLSGSPLQPIPA | 121 | O15446 | |
| ARPSQGLPVIQSPPS | 1431 | Q9HCD6 | |
| VLSPTSPGNLPQPES | 1876 | Q9HCD6 | |
| PNLPSPGTLAPTTLQ | 451 | Q03519 | |
| QPLPLPQTLPRGQSL | 556 | Q6ZUB0 | |
| GIQLPVQPTAVPAQP | 691 | Q15714 | |
| STQVPPSVIQQGAPP | 746 | Q15714 | |
| LLTVPPQPQGVEPVA | 796 | Q15714 | |
| LTPELQGILPSQPPV | 1026 | Q9NQW1 | |
| GTSPLVLTPAPAQIP | 56 | P59797 | |
| LPIPTPNPLTTLGVS | 11 | Q8WXA9 | |
| IPTLEAVVGVPQPPS | 966 | P20701 | |
| ELSAQPTPGPVPQVL | 1031 | Q6ZRS2 | |
| LLPPLQPNSGSLPQV | 1071 | Q6ZRS2 | |
| QPNSGSLPQVLPSPL | 1076 | Q6ZRS2 | |
| QAVAPTPGPTPVSVL | 1261 | Q6ZRS2 | |
| QTLTLSPAPVPTLGP | 1786 | Q6ZRS2 | |
| TPAPVIGLTSPSVQP | 921 | Q9NZP6 | |
| GNPPPTLLPSQETER | 206 | Q9NPQ8 | |
| DTPSGLVPLQPKTPQ | 536 | Q8TAQ2 | |
| PNLHPGLVSTPISPQ | 301 | Q01826 | |
| PVGETSPAIQLPTPA | 461 | O94993 | |
| TSPLPAGQVPVTLQP | 181 | P63128 | |
| GPSVPTSPVGQLLPE | 656 | P35498 | |
| SVPLSILQTPTPQPL | 126 | P36956 | |
| ILQTPTPQPLPGALL | 131 | P36956 | |
| DPDPTTQPIVLLLPG | 116 | Q96SE0 | |
| PQSIFVTNPVTLTPP | 2156 | Q8IWZ3 | |
| TLTPPQGPPAAVQLS | 2166 | Q8IWZ3 | |
| TVLLQSLVQPPPVSP | 266 | Q99941 | |
| SLVQPPPVSPVVLIQ | 271 | Q99941 | |
| APTPGIPILQSVPSA | 881 | Q96RK0 | |
| GAQPPSKIIQLTPVP | 956 | Q96RK0 | |
| IPQQPPGSLSIASPN | 831 | Q9C0B9 | |
| SLQVIEPEPGQSPPR | 461 | Q7Z2D5 | |
| QPLPLPQTLPRGQSL | 556 | P0C874 | |
| PQLIGRPPSASQTPV | 2411 | Q86UP3 | |
| SLPQPPGSQVPLEVT | 71 | Q6ZSR3 | |
| TTPVNLPTPVTAPVN | 461 | Q14119 | |
| VTPAASPSLPQPGLQ | 196 | O15027 | |
| LPTPNPLTQIGAVPL | 141 | Q05519 | |
| QGPPFIVSPPENITV | 226 | Q9UPX0 | |
| GAPTQLLTESPPTPL | 226 | Q02086 | |
| QTLAVPVGLPSVPPL | 86 | A6NCQ9 | |
| IQPAPISTQGIQPAP | 561 | Q9H0E3 | |
| PLPTTEGTPGLPLQQ | 571 | Q9C0C2 | |
| TPLPVDPRVNITPSG | 381 | Q92626 | |
| IQTPGPLPAPQLTST | 1106 | Q8WVM7 | |
| PPPIILQGPANQTLA | 416 | Q9HCK4 | |
| NVIILQPPSTTPCPT | 551 | Q68DE3 | |
| SPQPIGIVVAAVPSP | 256 | Q2KHR2 | |
| ISQSTPVFPPGSLPI | 436 | Q12888 | |
| PQETQGPPARPITVQ | 176 | P43489 | |
| QPATVLQTVPGVPPL | 501 | Q9H869 | |
| IPQNTGTPQRVLPPV | 6 | A8MUI8 | |
| IGTGSQPEVIPVPLP | 1006 | Q9Y2L5 | |
| EQLRQPPLPTSSPGV | 691 | Q5SXM2 | |
| SPIIDGQQQSETPPP | 326 | Q8N680 | |
| PQINPSTSLPLIGSP | 196 | Q8ND82 | |
| QLPVSQPVPTIQGEP | 791 | Q9H4A3 | |
| QPVPTIQGEPQIPVA | 796 | Q9H4A3 | |
| AGPTSTPLLPQVPSI | 1586 | Q9H4A3 | |
| TELPAGTLPSEQLPP | 1766 | Q9H4A3 | |
| LATSQLPSPPLGPTV | 1546 | Q9Y3S1 | |
| ILIQDIPLPGAQPPS | 151 | Q9Y2W2 | |
| NVPFILSPVLQPEGP | 86 | Q5JPB2 | |
| SQPEEQGVTSPNIPP | 496 | O60315 | |
| QGVTSPNIPPVGLPV | 501 | O60315 | |
| LTTLPPPTPSQINAV | 281 | Q5VYS8 | |
| SPVNVPPAVQIPLTT | 496 | Q9Y2D9 | |
| PLLQTTQGLKPVSPP | 231 | Q14679 | |
| PLPQVPQLPSEGKST | 411 | Q6N021 | |
| LVTLPLDPPVVVPGQ | 501 | Q9Y334 | |
| PLVLPSPLVTPGSNS | 466 | Q96QC0 | |
| PVQQPSTPGPDLLAL | 21 | Q8N6V9 | |
| TSPEPQLPNSPTGVV | 236 | A6NGD5 | |
| PSVTPVPQLSQELPG | 441 | P18583 | |
| VPQLSQELPGLPAPS | 446 | P18583 | |
| PFPETQPGPLTLELQ | 306 | Q12836 | |
| PTQTPGLEPTTLQPT | 1076 | Q9BYP7 | |
| LPQPPSQPLSSVVVN | 206 | Q96CT2 | |
| GQQPPPPLRVNVVLS | 216 | Q496Y0 | |
| EVPSVLGTPLLQPPE | 1196 | O15069 |